<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6292605</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0208936</article-id><article-id pub-id-type="publisher-id">PONE-D-18-24488</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Bioengineering</subject><subj-group><subject>Synthetic Bioengineering</subject><subj-group><subject>Genome Engineering</subject><subj-group><subject>Synthetic Genome Editing</subject><subj-group><subject>Crispr</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Engineering and Technology</subject><subj-group><subject>Bioengineering</subject><subj-group><subject>Synthetic Bioengineering</subject><subj-group><subject>Genome Engineering</subject><subj-group><subject>Synthetic Genome Editing</subject><subj-group><subject>Crispr</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Synthetic Biology</subject><subj-group><subject>Synthetic Bioengineering</subject><subj-group><subject>Genome Engineering</subject><subj-group><subject>Synthetic Genome Editing</subject><subj-group><subject>Crispr</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Engineering and Technology</subject><subj-group><subject>Synthetic Biology</subject><subj-group><subject>Synthetic Bioengineering</subject><subj-group><subject>Genome Engineering</subject><subj-group><subject>Synthetic Genome Editing</subject><subj-group><subject>Crispr</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Synthetic Biology</subject><subj-group><subject>Synthetic Genomics</subject><subj-group><subject>Synthetic Genome Editing</subject><subj-group><subject>Crispr</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Engineering and Technology</subject><subj-group><subject>Synthetic Biology</subject><subj-group><subject>Synthetic Genomics</subject><subj-group><subject>Synthetic Genome Editing</subject><subj-group><subject>Crispr</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Cloning</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Cloning</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene Expression</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and Neoplasms</subject><subj-group><subject>Blastomas</subject><subj-group><subject>Nephroblastoma</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Molecular biology</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Sequencing techniques</subject><subj-group><subject>RNA sequencing</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Sequencing techniques</subject><subj-group><subject>RNA sequencing</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Molecular biology</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Sequencing techniques</subject><subj-group><subject>DNA sequencing</subject><subj-group><subject>Dideoxy DNA sequencing</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Sequencing techniques</subject><subj-group><subject>DNA sequencing</subject><subj-group><subject>Dideoxy DNA sequencing</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Histology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Histology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Renal System</subject><subj-group><subject>Kidneys</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Renal System</subject><subj-group><subject>Kidneys</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>A unique subset of low-risk Wilms tumors is characterized by loss of function of <italic>TRIM28 (KAP1)</italic>, a gene critical in early renal development: A Children&#x02019;s Oncology Group study</article-title><alt-title alt-title-type="running-head"><italic>TRIM28</italic> loss of function in a subset of Wilms tumors</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7784-0476</contrib-id><name><surname>Armstrong</surname><given-names>Amy E.</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gadd</surname><given-names>Samantha</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Huff</surname><given-names>Vicki</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gerhard</surname><given-names>Daniela S.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9037-369X</contrib-id><name><surname>Dome</surname><given-names>Jeffrey S.</given-names></name><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6853-6221</contrib-id><name><surname>Perlman</surname><given-names>Elizabeth J.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Division of Hematology-Oncology and Transplantation, Ann &#x00026; Robert H. Lurie Children&#x02019;s Hospital of Chicago, Northwestern University&#x02019;s Feinberg School of Medicine, Chicago, Illinois, United States of America</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Department of Pathology and Laboratory Medicine, Ann &#x00026; Robert H. Lurie Children&#x02019;s Hospital of Chicago, Northwestern University&#x02019;s Feinberg School of Medicine and Robert H. Lurie Cancer Center, Chicago, Illinois, United States of America</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland, United States of America</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Division of Pediatric Hematology/Oncology, Children's National Medical Center, Washington, District of Columbia, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Brown</surname><given-names>Keith William</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of Bristol, UNITED KINGDOM</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>eperlman@luriechildrens.org</email></corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>12</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>13</volume><issue>12</issue><elocation-id>e0208936</elocation-id><history><date date-type="received"><day>20</day><month>8</month><year>2018</year></date><date date-type="accepted"><day>26</day><month>11</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 Armstrong et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Armstrong et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0208936.pdf"/><abstract><p>This study explores the genomic alterations that contribute to the formation of a unique subset of low-risk, epithelial differentiated, favorable histology Wilms tumors (WT), tumors that have been characterized by their expression of post-induction renal developmental genes (Subset 1 WT). We demonstrate copy neutral loss of heterozygosity involving 19q13.32-q13.43, unaccompanied by evidence for imprinting by DNA methylation. We further identified loss-of-function somatic mutations in <italic>TRIM28</italic> (also known as KAP1), located at 19q13, in 8/9 Subset 1 tumors analyzed. An additional germline <italic>TRIM28</italic> mutation was identified in one patient. Retrospective evaluation of previously analyzed WT outside of Subset 1 identified an additional tumor with anaplasia and both <italic>TRIM28</italic> and <italic>TP53</italic> mutations. A major function of TRIM28 is the repression of endogenous retroviruses early in development. We depleted <italic>TRIM28</italic> in HEK293 cells, which resulted in increased expression of endogenous retroviruses, a finding also demonstrated in <italic>TRIM28</italic>-mutant WT. TRIM28 has been shown by others to be active during early renal development, and to interact with WTX, another gene recurrently mutated in WT. Our findings suggest that inactivation of TRIM28 early in renal development contributes to the formation of this unique subset of FHWTs, although the precise manner in which TRIM28 impacts both normal renal development and oncogenesis remains elusive.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000009</institution-id><institution>Foundation for the National Institutes of Health</institution></institution-wrap></funding-source><award-id>U10CA98543</award-id></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000009</institution-id><institution>Foundation for the National Institutes of Health</institution></institution-wrap></funding-source><award-id>U24 CA114766</award-id></award-group><award-group id="award003"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000009</institution-id><institution>Foundation for the National Institutes of Health</institution></institution-wrap></funding-source><award-id>U10CA180886</award-id></award-group><award-group id="award004"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000009</institution-id><institution>Foundation for the National Institutes of Health</institution></institution-wrap></funding-source><award-id>UO1CA88131</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6853-6221</contrib-id><name><surname>Perlman</surname><given-names>Elizabeth J.</given-names></name></principal-award-recipient></award-group><funding-statement>This work was supported by TARGET National Institutes of Health (NIH) U10 CA98543 contract HHSN261200800001E (EJP); NIH U10CA42326 (EJP); NIH U10CA98543 (JSD, EJP); NIH U24 CA114766 (EJP, JSD); NIH U10CA180886 (JSD, EJP); UO1CA88131 (EJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="2"/><page-count count="15"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>The sequencing FASTQ files are deposited in the Sequence Read Archive at the National Center for Biotechnology Information, and are accessible through dbGAP, (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000218">https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000218</ext-link>) under the accession number phs000471 (See Supplemental Material for sample identification numbers). Chromosome segmental copy number, genotype, sequence analysis (e.g. MAF and summary files), and the clinical information are available through the TARGET Data Matrix (<ext-link ext-link-type="uri" xlink:href="https://ocg.cancer.gov/programs/target/data-matrix">https://ocg.cancer.gov/programs/target/data-matrix</ext-link>). All other relevant data are contained within the manuscript and its Supporting Information Files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>The sequencing FASTQ files are deposited in the Sequence Read Archive at the National Center for Biotechnology Information, and are accessible through dbGAP, (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000218">https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000218</ext-link>) under the accession number phs000471 (See Supplemental Material for sample identification numbers). Chromosome segmental copy number, genotype, sequence analysis (e.g. MAF and summary files), and the clinical information are available through the TARGET Data Matrix (<ext-link ext-link-type="uri" xlink:href="https://ocg.cancer.gov/programs/target/data-matrix">https://ocg.cancer.gov/programs/target/data-matrix</ext-link>). All other relevant data are contained within the manuscript and its Supporting Information Files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Wilms tumor (WT), the most common renal malignancy in childhood, demonstrates a striking histologic replication of early renal development. Most WTs originate during embryonic development from disruption of mesenchymal-epithelial transition, which in the kidney is known as induction [<xref rid="pone.0208936.ref001" ref-type="bibr">1</xref>&#x02013;<xref rid="pone.0208936.ref003" ref-type="bibr">3</xref>]. Therefore, increased understanding of the normal early renal developmental processes may elucidate the origins of WT, and <italic>vice versa</italic>. Through analysis of global gene expression patterns, we previously recognized five subsets of WT that differed in their clinical and pathologic characteristics [<xref rid="pone.0208936.ref004" ref-type="bibr">4</xref>]. Subset 1 (S1) (~5% of FHWTs) are exclusively epithelial tumors most commonly detected in infancy; they do not relapse, have a very low incidence of 11p15 loss of heterozygosity (LOH)/loss of imprinting (LOI), and show a post-induction gene expression pattern. In contrast, Subset 5 tumors (S5) (~70% of FHWTs) show a wide range of histologic patterns, arise at a median age of 43.5 months, have a high frequency of 11p15 LOH/LOI, and display the gene expression pattern of pre-induction metanephric mesenchyme. Subsequently, we and others reported recurrent gene mutations in the majority of WT, with specific mutations occurring with different prevalence in different subsets [<xref rid="pone.0208936.ref005" ref-type="bibr">5</xref>&#x02013;<xref rid="pone.0208936.ref011" ref-type="bibr">11</xref>]. However, these studies (which were confined to high risk WT) did not include the low-risk S1 tumors. In this study we performed comprehensive genomic analysis of S1 tumors, resulting in the identification of recurrent (8/9 patients) mutations in <italic>TRIM28</italic>, a gene previously recognized to be important both in renal development and in carcinogenesis [<xref rid="pone.0208936.ref012" ref-type="bibr">12</xref>]. This work extends the recent report of <italic>TRIM28</italic> mutation in four patients with S1 tumors [<xref rid="pone.0208936.ref013" ref-type="bibr">13</xref>]. Through the analysis of an unselected group of patients with WT, we are able to provide the full clinical context of <italic>TRIM28</italic> mutations in WT, including an additional patient with anaplasia and mutations in both <italic>TRIM28</italic> and <italic>TP53</italic>, and a patient with both germline and somatic TRIM28 mutations. Through the investigation of the functional impact of TRIM28 depletion in HEK293 cells we demonstrate over-expression of endogenous retroviruses (ERVs) and associated zinc finger proteins (ZFPs) following TRIM28 depletion, findings we also document in <italic>TRIM28</italic>-mutant WTs, thereby validating the functional significance of these mutations.</p></sec><sec sec-type="results" id="sec002"><title>Results</title><p>Of eleven S1 FHWTs previously defined and described [<xref rid="pone.0208936.ref004" ref-type="bibr">4</xref>], DNA was available for nine, and these represent the focus of the current study (<bold><xref rid="pone.0208936.t001" ref-type="table">Table 1</xref>).</bold> PAJMKN and PAKVET were analyzed within the TARGET initiative using whole exomic sequencing and RNA sequencing. All 9 S1 tumors were included in the TARGET validation set which was analyzed by targeted sequencing for recurrent mutations identified within the TARGET discovery set. The five S1 pilot tumors examined for copy number analysis and methylation analysis are indicated (<sup>a</sup>). All tumors were exclusively of epithelial histology, none had associated nephrogenic rests, and none relapsed.</p><table-wrap id="pone.0208936.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0208936.t001</object-id><label>Table 1</label><caption><title>Pathogenic <italic>TRIM28</italic> variants identified in nine S1 favorable histology Wilms tumors.</title></caption><alternatives><graphic id="pone.0208936.t001g" xlink:href="pone.0208936.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" style="border-top:thick;border-bottom:thick" rowspan="1" colspan="1">Sample</th><th align="center" style="border-top:thick;border-bottom:thick" rowspan="1" colspan="1">Age<break/>(months)</th><th align="center" style="border-top:thick;border-bottom:thick" rowspan="1" colspan="1">Initial<break/>Detection Method</th><th align="center" style="border-top:thick;border-bottom:thick" rowspan="1" colspan="1">Genomic Change: hg19<break/>(Protein Change:<break/>ENSP00000253024)</th><th align="center" style="border-top:thick;border-bottom:thick" rowspan="1" colspan="1">Exon</th><th align="center" style="border-top:thick;border-bottom:thick" rowspan="1" colspan="1">AF</th><th align="center" style="border-top:thick;border-bottom:thick" rowspan="1" colspan="1">Effect</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1"><xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref> PADWNP</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">Targeted seq</td><td align="center" rowspan="1" colspan="1">g.59058853C&#x0003e;T<break/>(p.Gln233x)</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">0.91</td><td align="center" rowspan="1" colspan="1">Nonsense</td></tr><tr><td align="center" rowspan="1" colspan="1"><xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref> PAJMKN</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">RNAseq</td><td align="center" rowspan="1" colspan="1">g.59056439_59056440 insCGGCGGGG<break/>(p.Asp105fs)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Frameshift ins</td></tr><tr><td align="center" rowspan="1" colspan="1"><xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref> PAJMZF</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">Targeted seq</td><td align="center" rowspan="1" colspan="1">g.59060404C&#x0003e;T<break/>(p.Arg487x)</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">0.51</td><td align="center" rowspan="1" colspan="1">Nonsense</td></tr><tr><td align="center" rowspan="1" colspan="1">PADDLL</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">Targeted seq</td><td align="center" rowspan="1" colspan="1">g.59060970_59060971<break/>delTT<break/>(p.Phe645fs)</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">0.91</td><td align="center" rowspan="1" colspan="1">Frameshift del</td></tr><tr><td align="center" rowspan="2" colspan="1">PAJPER</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">Targeted seq</td><td align="center" rowspan="1" colspan="1">g.59059081G&#x0003e;A</td><td align="center" rowspan="1" colspan="1">5&#x02013;6</td><td align="center" rowspan="1" colspan="1">0.48</td><td align="center" rowspan="1" colspan="1">Splice site</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Targeted seq</td><td align="center" rowspan="1" colspan="1">g.59060404C&#x0003e;T<break/>(p.Arg487x)</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">Nonsense</td></tr><tr><td align="center" rowspan="1" colspan="1">PAKSJN</td><td align="center" rowspan="1" colspan="1">91</td><td align="center" rowspan="1" colspan="1">Targeted seq</td><td align="center" rowspan="1" colspan="1">g.59058844C&#x0003e;T<break/>(p.Arg230x)</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">0.97</td><td align="center" rowspan="1" colspan="1">Nonsense</td></tr><tr><td align="center" rowspan="1" colspan="1"><xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref> PAKVET</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">WES</td><td align="center" rowspan="1" colspan="1">g.59059081G&#x0003e;A</td><td align="center" rowspan="1" colspan="1">5&#x02013;6</td><td align="center" rowspan="1" colspan="1">0.9</td><td align="center" rowspan="1" colspan="1">Splice site</td></tr><tr><td align="center" rowspan="1" colspan="1"><xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref> PAJNYM</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">Sanger</td><td align="center" rowspan="1" colspan="1">g.59056466T&#x0003e;G</td><td align="center" rowspan="1" colspan="1">1&#x02013;2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Splice site</td></tr><tr><td align="center" rowspan="1" colspan="1">PAJNID</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">Targeted seq</td><td align="center" rowspan="1" colspan="1">No variants detected</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>AF = allele frequency;</p></fn><fn id="t001fn002"><p><sup><bold>a</bold></sup> S1 pilot set tumors</p></fn></table-wrap-foot></table-wrap><sec id="sec003"><title>Evaluation of copy number and methylation</title><p>Five S1 pilot tumors were analyzed for copy number and methylation changes. The only recurrent copy number change seen in more than 2 of the 5 tumors was copy neutral loss of heterozygosity (CN-LOH) of chr19q13, present in all five tumors (<bold><xref ref-type="supplementary-material" rid="pone.0208936.s006">S1 Table</xref></bold> and <bold><xref ref-type="fig" rid="pone.0208936.g001">Fig 1</xref></bold>). All but one tumor (PAJMZF) demonstrated CN-LOH of almost the entire long arm of chromosome 19, 19q13.32 to 9q13.43. For verification, we evaluated the two TARGET cases for which both tumor and normal DNA was characterized by the Affymetrix SNP 6.0 platform; both cases had somatic large regions of CN-LOH (chr19q12-q13.43). We then compared the DNA methylation status of the 5 pilot S1 tumors with 11 clear cell sarcomas of the kidney (CCSK), which are genomically stable and lack CN and/or allelic imbalance on chr19 [<xref rid="pone.0208936.ref014" ref-type="bibr">14</xref>]. Neither hypo- nor hyper-methylation associated with 19q CN-LOH was detected.</p><fig id="pone.0208936.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0208936.g001</object-id><label>Fig 1</label><caption><title>Copy-neutral loss of heterozygosity on chromosome 19 in five S1 favorable histology Wilms tumors.</title><p>The beta allele frequency values from the Illumina Human 610-quad beadchip were filtered to include only regions on 19q for which the beta value is &#x0003c; 15% or &#x0003e; 85% for &#x02265; 10 consecutive probes. The filtered files were converted to .bed format and imported into IGV for visualization. The red arrow indicates the location of <italic>TRIM28</italic>. The regions were verified to have normal copy number using BioDiscovery Nexus 6.1 software (see <xref ref-type="supplementary-material" rid="pone.0208936.s009">S1 File</xref>).</p></caption><graphic xlink:href="pone.0208936.g001"/></fig></sec><sec id="sec004"><title>TRIM28 variant identification</title><p>No somatic variants were initially identified by WES within the two S1 tumors included in TARGET (PAJMKN and PAKVET). Neither the two TARGET S1 tumors analyzed by WES nor the 9 S1 tumors within the TARGET validation set contained any of the recurrent mutations previously identified in WT [<xref rid="pone.0208936.ref005" ref-type="bibr">5</xref>]. Therefore, we turned to the TARGET RNAseq data performed on PAJMKN and PAKVET. In PAJMKN, a novel internal tandem duplication (ITD) was identified in exon 1 of <italic>TRIM28</italic> (g.chr19:59056439_59056440insCGGCGGGG). We amplified this GC-rich region in the genomic DNA by utilizing PCR enhancer reagents (see <xref ref-type="supplementary-material" rid="pone.0208936.s009">S1 File</xref>) and submitted the amplicon for Sanger sequencing, which confirmed the ITD to be homozygous (<bold><xref ref-type="supplementary-material" rid="pone.0208936.s001">S1 Fig</xref></bold>). No other variants were identified in either PAJMKN or PAKVET by RNAseq. We assessed the 8 additional S1 tumors for this ITD mutation using Sanger sequencing; none had the ITD but we discovered a nearby splice-site variant between <italic>TRIM28</italic> exons 1 and 2 in PAJNYM (g.chr19:59056466T&#x0003e;G) (<bold><xref ref-type="supplementary-material" rid="pone.0208936.s001">S1 Fig</xref></bold>). Deeper examination of the WES data for PAKVET revealed a novel variant in a conserved splice site between exons 5 and 6 of <italic>TRIM28</italic> (g.chr19:59059081G&#x0003e;A). This variant was also present in the paired normal sample and was therefore not initially detected as somatic. The variant allelic fraction was 61% and 93% in the paired normal and tumor samples, respectively, confirmed by Sanger Sequencing (<bold><xref ref-type="supplementary-material" rid="pone.0208936.s001">S1 Fig</xref></bold>). (This tumor also showed LOH for 19q). Only 22% (18/82) of the RNA reads of the tumor sample retained the normal splice junction, whereas 72% (59/82) were abnormally spliced (<bold><xref ref-type="supplementary-material" rid="pone.0208936.s002">S2 Fig</xref></bold>), resulting in frameshift deletion of 11 nucleotides at position S280.</p><p>We next performed targeted sequencing of the entire <italic>TRIM28</italic> gene (<italic>TRIM28</italic> was not included in the original targeted sequencing). High-quality mapped reads were obtained for exons 4 through 17; an adequate read depth could not be achieved for exons 1&#x02013;3 using targeted sequencing despite several attempts to optimize the primers/sequencing conditions. We successfully performed Sanger sequencing for exons 2 and 3 which revealed no further mutations. Nonsense, frameshift, or splice site mutations were identified in 6/7 tumors analyzed. In total, <italic>TRIM28</italic> mutations were identified in 8/9 S1 tumors tested (<bold><xref rid="pone.0208936.t001" ref-type="table">Table 1</xref> and <xref ref-type="fig" rid="pone.0208936.g002">Fig 2</xref></bold>). Of note, 6/8 S1 tumors demonstrated homozygous mutations (AF&#x0003e;90%, or presence of two different mutations). Only 1 tumor had an allelic fraction most consistent with heterozygous mutation, and this tumor (PAJMZF) is the pilot tumor that lacked clear 19p13.43 CN LOH. Methylation analysis of the <italic>TRIM28</italic> promoter in PAJMZF identified five sequential probes with very low beta values in the remaining 4 S1 tumors (average 1.7% +/- 0.7%) and CCSKs (average 1.3% +/- 0.3%), whereas the beta values for PAJMZF were an average of 30%. To determine if this resulted in decreased expression, we performed RT-PCR followed by Sanger sequencing for <italic>TRIM28</italic> in PAJMZF, which demonstrated a ratio of 70:30 wildtype:mutant allele. These findings suggest that hypermethylation of the <italic>TRIM28</italic> promoter in this case is unlikely to be responsible for silencing of the wild-type allele in PAJMZF, as was recently proposed [<xref rid="pone.0208936.ref013" ref-type="bibr">13</xref>].</p><fig id="pone.0208936.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0208936.g002</object-id><label>Fig 2</label><caption><title><italic>TRIM28</italic> mutations identified in Wilms tumors.</title><p>TRIM28 protein structure according to the UniProt database is illustrated using DOG 1.0 software (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.lcd-ustc.org/dog">http://bioinformatics.lcd-ustc.org/dog</ext-link>). TRIM28 includes an N-terminal tripartite RBCC (Ring finger, two B-box zinc fingers, and a coiled coil) domain, which is necessary for interaction with the family of KRAB ZNF transcription factors, a central TIF1 signature sequence (TSS) domain, a HP1 (heterochromatin protein 1)-binding domain, a C terminal combination plant homeodomain (PHD), and a bromodomain. Illustrated are TRIM28 pathogenic mutations identified in 8 S1 tumors and in one anaplastic WT from this study, depicted in black font above the TRIM28 protein image. TRIM28 pathogenic mutations identified by Halliday et al [<xref rid="pone.0208936.ref013" ref-type="bibr">13</xref>] are depicted in gray font below the TRIM28 protein image. One mutation (a) was reported by Halliday et al. [<xref rid="pone.0208936.ref013" ref-type="bibr">13</xref>] in two siblings and their mother.</p></caption><graphic xlink:href="pone.0208936.g002"/></fig><p>Lastly, analysis of the sequencing data from the entire TARGET discovery set of 117 high risk WT identified a single patient with <italic>TRIM28</italic> mutation in an anaplastic, epithelial WT that also contained a mutation in <italic>TP53</italic>. This patient had the same conserved splice-site mutation found in PAKVET (g.chr19:59059081G&#x0003e;A), with 93% alternate reads in the tumor sample. Notably, this case had low <italic>TRIM28</italic> mRNA levels (log2 = 6.4) compared to the average expression level in all TARGET cases (log2 = 10.3 +/- 0.8). <bold><xref ref-type="fig" rid="pone.0208936.g002">Fig 2</xref></bold>provides the <italic>TRIM28</italic> mutation data for all <italic>TRIM28</italic>-mutant WTs, including those recently reported [<xref rid="pone.0208936.ref013" ref-type="bibr">13</xref>].</p></sec><sec id="sec005"><title>TRIM28 depletion effect on gene expression</title><p>The genetic expression pattern characterizing S1 tumors compared with other WT subsets has been previously reported [<xref rid="pone.0208936.ref004" ref-type="bibr">4</xref>]. To address the impact of <italic>TRIM28</italic> depletion on gene expression, we knocked out <italic>TRIM28</italic> in the human embryonal kidney HEK293 cell line using CRISPR. We identified three clones showing loss of both <italic>TRIM28</italic> mRNA and protein, and two clones showing <italic>TRIM28</italic> mRNA and protein levels comparable to that seen in the HEK293 parent line (see <bold><xref ref-type="supplementary-material" rid="pone.0208936.s003">S3</xref> and <xref ref-type="supplementary-material" rid="pone.0208936.s004">S4</xref> Figs</bold>); a frameshift-causing mutation in <italic>TRIM28</italic> was verified by Sanger sequencing in CRISPR clones with loss of TRIM28 mRNA and protein (<bold><xref ref-type="supplementary-material" rid="pone.0208936.s005">S5 Fig</xref></bold>). The gene expression patterns of the three <italic>TRIM28</italic> knockdown clones were compared to two clones with normal <italic>TRIM28</italic> expression and with the HEK293 parent cell line using Statistical Analysis for Microarrays. We found 20 differentially expressed genes with q &#x0003c; 0.1 (<bold><xref rid="pone.0208936.t002" ref-type="table">Table 2</xref></bold>), including <italic>TRIM28</italic> (q &#x0003c; 0.0001; fold change = 0.052) and 18 <italic>ZNF</italic> genes overexpressed in the <italic>TRIM28</italic> knockdown clones. This is in keeping with previous studies demonstrating that essentially all of the top-ranked TRIM28 targets in Ntera2 cells were <italic>ZNF</italic> genes [<xref rid="pone.0208936.ref015" ref-type="bibr">15</xref>]. <italic>APOBEC3B/A</italic>, which is also over-expressed following <italic>TRIM28</italic> depletion, also has an established role in restricting infectivity of certain retroviruses [<xref rid="pone.0208936.ref016" ref-type="bibr">16</xref>]. Only seven of these 20 genes were represented in the Affymetrix U133A array used in the original report of genes defining the S1 subset [<xref rid="pone.0208936.ref004" ref-type="bibr">4</xref>] (identified by an asterisk in <xref rid="pone.0208936.t002" ref-type="table">Table 2</xref>). Of these seven genes, only <italic>TRIM28</italic> was differentially expressed.</p><table-wrap id="pone.0208936.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0208936.t002</object-id><label>Table 2</label><caption><title>Significant differentially expressed genes in <italic>TRIM28</italic> CRISPR clones.</title></caption><alternatives><graphic id="pone.0208936.t002g" xlink:href="pone.0208936.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Gene Name</th><th align="center" rowspan="1" colspan="1">Location</th><th align="center" rowspan="1" colspan="1">Score(d)</th><th align="center" rowspan="1" colspan="1">Fold Change</th><th align="center" rowspan="1" colspan="1">q-value(%)</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">APOBEC3B/A<xref ref-type="table-fn" rid="t002fn001">*</xref></td><td align="center" rowspan="1" colspan="1">22q13.1</td><td align="center" rowspan="1" colspan="1">3.281</td><td align="center" rowspan="1" colspan="1">7.727</td><td align="center" rowspan="1" colspan="1">0.000</td></tr><tr><td align="center" rowspan="1" colspan="1">TRIM28<xref ref-type="table-fn" rid="t002fn001">*</xref></td><td align="center" rowspan="1" colspan="1">19q13.43</td><td align="center" rowspan="1" colspan="1">-5.102</td><td align="center" rowspan="1" colspan="1">0.052</td><td align="center" rowspan="1" colspan="1">0.000</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF135<xref ref-type="table-fn" rid="t002fn001">*</xref></td><td align="center" rowspan="1" colspan="1">19q13.43</td><td align="center" rowspan="1" colspan="1">2.678</td><td align="center" rowspan="1" colspan="1">15.889</td><td align="center" rowspan="1" colspan="1">9.627</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF28</td><td align="center" rowspan="1" colspan="1">19q13.41</td><td align="center" rowspan="1" colspan="1">3.547</td><td align="center" rowspan="1" colspan="1">4.993</td><td align="center" rowspan="1" colspan="1">0.000</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF347</td><td align="center" rowspan="1" colspan="1">19q13.42</td><td align="center" rowspan="1" colspan="1">3.013</td><td align="center" rowspan="1" colspan="1">4.199</td><td align="center" rowspan="1" colspan="1">5.946</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF354C</td><td align="center" rowspan="1" colspan="1">5q35.3</td><td align="center" rowspan="1" colspan="1">3.836</td><td align="center" rowspan="1" colspan="1">7.745</td><td align="center" rowspan="1" colspan="1">0.000</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF486<xref ref-type="table-fn" rid="t002fn001">*</xref></td><td align="center" rowspan="1" colspan="1">19p12</td><td align="center" rowspan="1" colspan="1">3.999</td><td align="center" rowspan="1" colspan="1">4.209</td><td align="center" rowspan="1" colspan="1">0.000</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF528<xref ref-type="table-fn" rid="t002fn001">*</xref></td><td align="center" rowspan="1" colspan="1">19q13.41</td><td align="center" rowspan="1" colspan="1">4.140</td><td align="center" rowspan="1" colspan="1">5.327</td><td align="center" rowspan="1" colspan="1">0.000</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF578</td><td align="center" rowspan="1" colspan="1">19q13.41</td><td align="center" rowspan="1" colspan="1">2.963</td><td align="center" rowspan="1" colspan="1">3.564</td><td align="center" rowspan="1" colspan="1">5.946</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF610</td><td align="center" rowspan="1" colspan="1">19q13.41</td><td align="center" rowspan="1" colspan="1">2.620</td><td align="center" rowspan="1" colspan="1">4.702</td><td align="center" rowspan="1" colspan="1">9.627</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF611<xref ref-type="table-fn" rid="t002fn001">*</xref></td><td align="center" rowspan="1" colspan="1">19q13.41</td><td align="center" rowspan="1" colspan="1">2.609</td><td align="center" rowspan="1" colspan="1">2.738</td><td align="center" rowspan="1" colspan="1">9.627</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF626</td><td align="center" rowspan="1" colspan="1">19p12</td><td align="center" rowspan="1" colspan="1">3.892</td><td align="center" rowspan="1" colspan="1">5.553</td><td align="center" rowspan="1" colspan="1">0.000</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF677</td><td align="center" rowspan="1" colspan="1">19q13.42</td><td align="center" rowspan="1" colspan="1">2.850</td><td align="center" rowspan="1" colspan="1">7.029</td><td align="center" rowspan="1" colspan="1">5.946</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF681</td><td align="center" rowspan="1" colspan="1">19p12</td><td align="center" rowspan="1" colspan="1">5.222</td><td align="center" rowspan="1" colspan="1">5.075</td><td align="center" rowspan="1" colspan="1">0.000</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF737</td><td align="center" rowspan="1" colspan="1">19p12</td><td align="center" rowspan="1" colspan="1">3.156</td><td align="center" rowspan="1" colspan="1">6.727</td><td align="center" rowspan="1" colspan="1">0.000</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF763</td><td align="center" rowspan="1" colspan="1">19p13.2</td><td align="center" rowspan="1" colspan="1">3.074</td><td align="center" rowspan="1" colspan="1">5.452</td><td align="center" rowspan="1" colspan="1">5.946</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF808</td><td align="center" rowspan="1" colspan="1">19q13.41</td><td align="center" rowspan="1" colspan="1">2.963</td><td align="center" rowspan="1" colspan="1">3.802</td><td align="center" rowspan="1" colspan="1">5.946</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF83<xref ref-type="table-fn" rid="t002fn001">*</xref></td><td align="center" rowspan="1" colspan="1">19q13.41</td><td align="center" rowspan="1" colspan="1">3.373</td><td align="center" rowspan="1" colspan="1">9.021</td><td align="center" rowspan="1" colspan="1">0.000</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF850</td><td align="center" rowspan="1" colspan="1">19q13.12</td><td align="center" rowspan="1" colspan="1">2.602</td><td align="center" rowspan="1" colspan="1">2.378</td><td align="center" rowspan="1" colspan="1">9.627</td></tr><tr><td align="center" rowspan="1" colspan="1">ZNF883</td><td align="center" rowspan="1" colspan="1">9q32</td><td align="center" rowspan="1" colspan="1">4.333</td><td align="center" rowspan="1" colspan="1">12.126</td><td align="center" rowspan="1" colspan="1">0.000</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>* Genes also represented in the original report of genes defining the S1 subset [<xref rid="pone.0208936.ref004" ref-type="bibr">4</xref>]</p></fn></table-wrap-foot></table-wrap><p>The available TARGET RNAseq data was then used to compare the three <italic>TRIM28</italic>-mutant WT (two S1 tumors and 1 anaplastic tumor) with six randomly selected <italic>TRIM28</italic>-wild-type WT using DESeq2 (adjusted p&#x0003c;0.01, <bold><xref ref-type="supplementary-material" rid="pone.0208936.s007">S2 Table</xref></bold>). <italic>TRIM28</italic> was found to be down-regulated (log 2 fold change (FC) -4.09, adjusted p = 1.16E-15). In addition, the expression of four <italic>KRAB-ZNFs</italic> was increased (<italic>ZNF728</italic> (p = 2.1e-06, log2 FC = 5), <italic>ZNF676</italic> (p = 0.00016, log2 FC = 4), <italic>ZNF208</italic> (p = 0.0003, log2 FC = 4.3), and <italic>ZNF780A</italic>, (p = 0.009, log2 FC 1.7). TRIM28 has been shown to repress transposable elements (TEs) in embryonic stem cells and neural progenitor cells via recruitment by KRAB-ZNF proteins [<xref rid="pone.0208936.ref017" ref-type="bibr">17</xref>&#x02013;<xref rid="pone.0208936.ref022" ref-type="bibr">22</xref>] and depletion of <italic>TRIM28</italic> results in increased expression of both TEs and ZNFs [<xref rid="pone.0208936.ref021" ref-type="bibr">21</xref>]. Therefore, the TARGET RNAseq data was analyzed for differences in TE expression between the three <italic>TRIM28</italic>-mutant WT (two S1 tumors and 1 anaplastic tumor) and the six randomly selected <italic>TRIM28</italic>-wild-type WT (see <xref ref-type="sec" rid="sec007">methods</xref>), revealing differential expression (p&#x0003c;0.001) of 787 TEs overall; 172 of these TEs are classified as ERVs) (<bold><xref ref-type="supplementary-material" rid="pone.0208936.s008">S3 Table</xref></bold>), and 161/172 (94%) of these ERVs are over-expressed in <italic>TRIM28</italic>-mutated tumors, with a median log2 fold change of 6.9. While we were not able to determine global TE expression in <italic>TRIM28</italic> CRISPR clones (Clariom D array lacks probes for these elements), RT-PCR performed on four ERVs differentially expressed in the <italic>TRIM28</italic> mutant WT showed increased expression of 3 of the 4 ERVs within the <italic>TRIM28</italic> depleted clones (<bold><xref ref-type="fig" rid="pone.0208936.g003">Fig 3</xref></bold>). Lastly, we compared the genes in <xref ref-type="supplementary-material" rid="pone.0208936.s007">S2 Table</xref> with the 100 genes previously reported to most significantly characterize S1 tumors [<xref rid="pone.0208936.ref004" ref-type="bibr">4</xref>], and identified 18 genes in common (indicated with an asterisk in <bold><xref ref-type="supplementary-material" rid="pone.0208936.s007">S2 Table</xref>).</bold> These include low expression of <italic>LEF1</italic>, <italic>MEIS1</italic>, <italic>MEIS2</italic>, <italic>HMGA2</italic>, <italic>SIX2</italic>, and <italic>TRIM28</italic>.</p><fig id="pone.0208936.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0208936.g003</object-id><label>Fig 3</label><caption><title>Human endogenous retrovirus expression in <italic>TRIM28</italic> CRISPR clones.</title><p>The expression of four human endogenous retroviruses up-regulated in <italic>TRIM28</italic>-mutant WT was evaluated in HEK293 cells (HEK293 parent), two CRISPR clones with normal <italic>TRIM28</italic> gene and protein levels (CRISPR Ctrl 1 and 2), and three <italic>TRIM28</italic> knockdown CRISPR clones (CRISPR Clone 1, 2, and 3) by SYBR Green PCR. The endogenous retrovirus levels were normalized to <italic>GAPDH</italic> and are presented as the relative quantitative (RQ) value compared to HEK293 parent cells. Error bars represent the standard deviation of two PCR replicates.</p></caption><graphic xlink:href="pone.0208936.g003"/></fig></sec></sec><sec sec-type="conclusions" id="sec006"><title>Discussion</title><p>We report recurrent loss-of-function mutations of <italic>TRIM28</italic> in a subset of low-risk epithelial WTs typically arising in infancy. As previously reviewed, pathogenic mutation of <italic>TRIM28</italic> had not been reported prior to its recent recognition in this unique subset of WT [<xref rid="pone.0208936.ref013" ref-type="bibr">13</xref>]. TRIM28 (also known as KAP1, TIF1) was identified as an interaction partner of the family of Kruppel-associated box domain-containing zinc finger transcription factors (KRAB-ZNFs) in 1996 by several laboratories [<xref rid="pone.0208936.ref023" ref-type="bibr">23</xref>&#x02013;<xref rid="pone.0208936.ref025" ref-type="bibr">25</xref>]. <italic>TRIM28</italic> is critical for early differentiation and development [<xref rid="pone.0208936.ref012" ref-type="bibr">12</xref>]. A number of reports have also associated overexpression of <italic>TRIM28</italic> with aggressiveness or poor outcome in adult cancers, specifically in breast, gastric, pancreatic, and brain tumors [<xref rid="pone.0208936.ref026" ref-type="bibr">26</xref>&#x02013;<xref rid="pone.0208936.ref029" ref-type="bibr">29</xref>], although the mechanisms proposed are varied and perplexing [<xref rid="pone.0208936.ref030" ref-type="bibr">30</xref>].</p><p>TRIM28 is a scaffold protein that recruits chromatin modifying factors (including the histone deacetylase complex NuRD and histone H3 lysine 9-specific methyltransferase SETDB1), thereby establishing repressive histone modifications [<xref rid="pone.0208936.ref031" ref-type="bibr">31</xref>,<xref rid="pone.0208936.ref032" ref-type="bibr">32</xref>]. TRIM28 itself does not bind to DNA, and requires recruitment by KRAB-ZFPs to specific genomic sites [<xref rid="pone.0208936.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0208936.ref023" ref-type="bibr">23</xref>]. The dominant DNA sequences to which the TRIM28 complex is recruited are those coding the KRAB-ZFPs themselves [<xref rid="pone.0208936.ref015" ref-type="bibr">15</xref>]. The best studied function of TRIM28 is its role in silencing transposable elements (TEs) [<xref rid="pone.0208936.ref033" ref-type="bibr">33</xref>,<xref rid="pone.0208936.ref034" ref-type="bibr">34</xref>]. Most TRIM28/KRAB-ZF protein complexes bind to thousands of TEs (particularly to ERVs) in both mouse and human embryonic stem cells [<xref rid="pone.0208936.ref035" ref-type="bibr">35</xref>&#x02013;<xref rid="pone.0208936.ref040" ref-type="bibr">40</xref>]. ERVs undergo TRIM28/H3K9me3-mediated silencing during the first few days of embryogenesis [<xref rid="pone.0208936.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0208936.ref017" ref-type="bibr">17</xref>]. When these early cells differentiate into various somatic cell types, the H3K9me3 histone-mediated repression is followed by DNA methylation, resulting in stable silencing of endogenous retroviruses (ERVs) [<xref rid="pone.0208936.ref041" ref-type="bibr">41</xref>&#x02013;<xref rid="pone.0208936.ref043" ref-type="bibr">43</xref>]. Importantly, this TRIM28-induced transcriptional silencing is able to spread over long genomic distances [<xref rid="pone.0208936.ref044" ref-type="bibr">44</xref>]. Many ERVs during evolution have inserted into precise genomic locations, and when these locations are situated near developmental genes, TRIM28-mediated repression may extend to these nearby genes [<xref rid="pone.0208936.ref018" ref-type="bibr">18</xref>]. This has been best exemplified in brain development [<xref rid="pone.0208936.ref032" ref-type="bibr">32</xref>]. TRIM28 depletion in mouse stem cells results in activation of TEs, particularly numerous ERVs, as well as many KRAB-ZFPs [<xref rid="pone.0208936.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0208936.ref021" ref-type="bibr">21</xref>,<xref rid="pone.0208936.ref045" ref-type="bibr">45</xref>]. The presence of increased expression of both ERVs and KRAB-ZNFs in the <italic>TRIM28</italic>-mutant WTs described in the current study raises the hypothesis that failure of TRIM28-mediated repression of ERV and nearby developmental genes early in renal development may result in failure to complete early epithelial differentiation, upsetting the balance between proliferation and differentiation. However, such mechanistic features will need to be clarified in future studies.</p><p>Reports are rapidly accumulating concerning the multifunctionality of TRIM28. In addition to its role in repression of ERVs early in development, TRIM28 has also been implicated in imprinting [<xref rid="pone.0208936.ref046" ref-type="bibr">46</xref>]. In addition, TRIM28 is involved in regulating transcription, including polymerase pausing [<xref rid="pone.0208936.ref047" ref-type="bibr">47</xref>]. It has recently been shown to facilitate the recruitment of P-TEFb to promoter-proximal regions allowing for productive transcript elongation, a major mechanism for controlling transcription [<xref rid="pone.0208936.ref048" ref-type="bibr">48</xref>]. Its actions may also be mediated through such factors as long-non-coding RNA [<xref rid="pone.0208936.ref049" ref-type="bibr">49</xref>]. The implication of the involvement of TRIM28 with the super elongation complex (of which P-TEFb is a member) is of particular interest in the context of WT, as mutations in <italic>MLLT1</italic> have been described in a different set of high-risk WTs [<xref rid="pone.0208936.ref011" ref-type="bibr">11</xref>]. MLLT1 has also been implicated in regulation of transcription elongation through its association with PAF, another member of the super elongation complex [<xref rid="pone.0208936.ref011" ref-type="bibr">11</xref>].</p><p>TRIM28 is functionally active during early embryonic development. Renal development begins within the undifferentiated metanephric (cap) mesenchyme located at the tips of the ureteric bud. Mesenchymal-to-epithelial transition (MET) occurs within the metanephric mesenchyme following Wnt activation signals provided by the adjacent ureteric bud. MET is followed by differentiation of the epithelial cells into the renal vesicle which then develop into the comma- and S-shaped bodies, a process that requires down-regulation of Wnt4 [<xref rid="pone.0208936.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0208936.ref050" ref-type="bibr">50</xref>&#x02013;<xref rid="pone.0208936.ref052" ref-type="bibr">52</xref>]. Proteomic analysis of the developing kidney recently revealed Trim28 to be highly expressed in the undifferentiated cap mesenchyme, however Trim28 was not expressed in the comma- and S-shaped bodies of the differentiating, elongating nephrons. Knockdown of Trim28 results in branching arrest of the ureteric bud, supporting an important role for Trim28 in kidney branching and morphogenesis [<xref rid="pone.0208936.ref053" ref-type="bibr">53</xref>]. TRIM28 has also been shown to interact with WTX, a protein that contributes to &#x003b2;-catenin degradation [<xref rid="pone.0208936.ref054" ref-type="bibr">54</xref>], and a gene inactivated frequently in WT [<xref rid="pone.0208936.ref055" ref-type="bibr">55</xref>]. The WTX-TRIM28 interaction occurs through the N-terminal coiled coil domain of TRIM28 (the same domain responsible for KRAB-ZNF binding and recruitment to chromatin) and through the C-terminal domain of WTX (the same domain responsible for binding WT1) [<xref rid="pone.0208936.ref056" ref-type="bibr">56</xref>]. Individual knock-down of either <italic>WTX</italic> or <italic>TRIM28</italic> result in highly overlapping transcriptomic impacts including both TEs and protein-coding sequences [<xref rid="pone.0208936.ref054" ref-type="bibr">54</xref>]. Kim et al also provide evidence that WTX/TRIM28 is involved in lineage specification through studies of adipocyte and osteoblastic models [<xref rid="pone.0208936.ref054" ref-type="bibr">54</xref>]. It is therefore perhaps not surprising that <italic>TRIM28</italic> mutation would result in abnormal epithelial development specific to that of the nephron. It is intriguing to consider that the loss of the WTX-TRIM28 interaction in this particular context may result in continued Wnt activation (which itself may prevent terminal epithelial differentiation [<xref rid="pone.0208936.ref057" ref-type="bibr">57</xref>], as well as continued proliferation and thereby altering the balance between proliferation and differentiation. TRIM28 depletion in breast and lung cancer cell lines has been shown to result in increased cell proliferation [<xref rid="pone.0208936.ref058" ref-type="bibr">58</xref>]. However, previous characterization of the global gene expression pattern of S1 tumors revealed a lack of Wnt activation in this WT subset [<xref rid="pone.0208936.ref004" ref-type="bibr">4</xref>], and analysis of the RNA-seq data from three TRIM28-mutant tumors in the present study also did not reveal an expression pattern consistent with Wnt activation. Finally, CRISPR-mediated knockdown of TRIM28 in HEK293 cells did not result in up-regulation of Wnt-associated genes. These data indicate that, despite the intriguing association between TRIM28 and WTX, loss of TRIM28 function in S1 tumors does not result in aberrant Wnt activation.</p><p>TRIM-28 mutant S1 tumors are of low-risk, with no evidence of recurrences. While this raises questions regarding their malignant potential, our review of the 117 high risk WTs revealed a single <italic>TRIM28</italic> mutation in a WT with diffuse anaplasia. This tumor showed an epithelial histology, was also identified as having a large region of CN-LOH of 19q, and also had a mutation in TP53, a finding that highly correlates with anaplasia in WT [<xref rid="pone.0208936.ref010" ref-type="bibr">10</xref>]. This suggests that while S1 tumors may have an excellent prognosis, this subset, like all other WT subsets, may develop secondary TP53 mutations resulting in the development of anaplasia. Lastly, of the nine S1 tumors sequenced in this study, one patient demonstrated a germ-line mutation with secondary copy-neutral LOH within the tumor, resulting in two mutant alleles. Halliday et al similarly identified germline TRIM28 mutations in two siblings, as well as in the peripheral blood of their mother [<xref rid="pone.0208936.ref013" ref-type="bibr">13</xref>].</p><p>In summary, we have identified mutations in <italic>TRIM28</italic> in a unique subset of low-risk epithelial WT and propose that <italic>TRIM28</italic> mutations contribute to aberrant nephron differentiation, resulting in WT formation. We have further shown that knockdown of <italic>TRIM28</italic> leads to upregulation of both KRAB-ZNF genes and endogenous retroviral families. The limitation of this study is that <italic>TRIM28</italic> depletion was performed in a cell line that does not accurately reflect the developmental context of the early developing kidney. Indeed, there are no such cell lines currently available. Therefore, to elucidate specific mechanisms resulting from <italic>TRIM28</italic> mutation requires a developmentally relevant system, such as TRIM28 depletion within renal organoids or conditional depletion in murine models.</p></sec><sec sec-type="materials|methods" id="sec007"><title>Materials and methods</title><sec id="sec008"><title>Clinical samples</title><p>Samples were obtained from patients prospectively registered on the National Wilms Tumor Study 5 (NWTS-5), previously described [<xref rid="pone.0208936.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0208936.ref059" ref-type="bibr">59</xref>]. Lurie Children&#x02019;s Hospital Institutional Review Board (IRB) approval for this study was obtained. Informed consent or parental authorization, as appropriate, were obtained as part of the initial sample collection. S1 and S5 subsets of FHWT were previously defined [<xref rid="pone.0208936.ref004" ref-type="bibr">4</xref>]; the current study includes nine of the original 11 S1 tumors for which DNA was available, and six randomly selected comparison S5 tumors. For additional comparison, we used data from previously reported clear cell sarcomas of the kidney (CCSK N = 11) [<xref rid="pone.0208936.ref014" ref-type="bibr">14</xref>]. Two of these 9 S1 tumors were comprehensively characterized through The National Cancer Institute&#x02019;s &#x0201c;Therapeutically Applicable Research to Generate Effective Treatments&#x0201d; (TARGET) initiative, although they were not included in previous publications which reported only high-risk WT. The sequencing FASTQ files are deposited in the Sequence Read Archive at the National Center for Biotechnology Information, and are accessible through dbGAP, (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000218">https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000218</ext-link>) under the accession number phs000471 (See <xref ref-type="supplementary-material" rid="pone.0208936.s009">S1 File</xref> for sample identification numbers). Chromosome segmental copy number, genotype, sequence analysis (e.g. MAF and summary files), and the clinical information are available through the TARGET Data Matrix (<ext-link ext-link-type="uri" xlink:href="https://ocg.cancer.gov/programs/target/data-matrix">https://ocg.cancer.gov/programs/target/data-matrix</ext-link>). These are annotated within MIAME compliant MAGE-TAB files fully describing the methods, the specimen processing details, and the quality control parameters. The remaining 7 S1 tumors were among the 651 WTs that underwent targeted sequencing in the TARGET validation set for genes recurrently mutated in WT within the TARGET discovery set [<xref rid="pone.0208936.ref005" ref-type="bibr">5</xref>].</p></sec><sec id="sec009"><title>Copy number and methylation analyses</title><p>At the time of the original gene expression study [<xref rid="pone.0208936.ref004" ref-type="bibr">4</xref>], a pilot set of five S1 tumors with available tissue were analyzed for copy number and methylation analysis. Copy number analysis was performed using the Illumina Human 610-quad beadchip, as described in <xref ref-type="supplementary-material" rid="pone.0208936.s009">S1 File</xref>.</p><p>Methylation analysis was performed using the Illumina Infinium Human Methylation 450K BeadChips according to the manufacturer&#x02019;s protocol using methods previously reported [<xref rid="pone.0208936.ref014" ref-type="bibr">14</xref>]. The average of the beta values for probes on 19q in the test set (S1 tumors) was compared with those of 11 CCSKs; regions were identified in which the average beta value for &#x02265; 5 consecutive probes ranged from 40&#x02013;60% in the comparison set and ranged from 0&#x02013;25% or from 75&#x02013;100% in the test set. The regions were visualized with Integrative Genomics Viewer [<xref rid="pone.0208936.ref060" ref-type="bibr">60</xref>, <xref rid="pone.0208936.ref061" ref-type="bibr">61</xref>].</p></sec><sec id="sec010"><title>Targeted sequencing of <italic>TRIM28</italic></title><p>Targeted sequencing of the full <italic>TRIM28</italic> gene was performed at GeneWiz (South Plainfield, NJ). In brief, primers were generated against the 17 <italic>TRIM28</italic> exons with flanking regions of ~100 bp plus the 5&#x02019; and 3&#x02019; UTR. Sequencing was performed using the Illumina MiSeq platform (paired end, 2 x 250 bp). Paired-end fastq files were processed using FASTQGroomer and Trimmomatic and mapped to the human reference genome (hg19) using BWA for Illumina with Galaxy software [<xref rid="pone.0208936.ref062" ref-type="bibr">62</xref>]. Variants were called using the FreeBayes algorithm and were annotated using ANNOVAR and Oncotator [<xref rid="pone.0208936.ref063" ref-type="bibr">63</xref>,<xref rid="pone.0208936.ref064" ref-type="bibr">64</xref>]. Variants detected by either WES or RNAseq were verified using Sanger sequencing using primers and amplification conditions described in <xref ref-type="supplementary-material" rid="pone.0208936.s009">S1 File</xref>. Sanger sequencing was performed on DNA from all S1 tumors for exons 2 and 3, and on RNA of PAJMZF to evaluate the ratio of the expressed reference and mutant alleles using the primers and amplification conditions described in <xref ref-type="supplementary-material" rid="pone.0208936.s009">S1 File</xref>. PCR products were purified using the QIAquick PCR Purification Kit (Qiagen, Germantown, MD) and sent to GeneWiz (South Plainfield, NJ) for sequencing.</p></sec><sec id="sec011"><title>Functional analysis of TRIM28 knockout</title><sec id="sec012"><title>CRISPR</title><p>Human embryonic kidney (HEK293) cells were transiently transfected with CRISPR RNA targeting exon 3 of <italic>TRIM28</italic> (crRNA) or non-targeting CRISPR RNA, transactivating RNA (tracrRNA) that forms a complex with crRNA and Cas9, and a Cas9-puromycin resistance expression plasmid (GE Dharmacon, LaFayette CO) using Lipofectamine (ThermoFisher) as described in <xref ref-type="supplementary-material" rid="pone.0208936.s009">S1 File</xref>. RNA samples from five resulting clones and from the HEK93 parent line were submitted to the NUSeq Core at Northwestern University for Clariom D microarray (ThermoFisher) gene expression analysis. CEL files were imported into Transcriptome Analysis Console 4.0 (ThermoFisher) and the data were processed using Expression (Gene + Exon) analysis type and Gene + Exon&#x02013;SST-RMA summarization (<ext-link ext-link-type="uri" xlink:href="https://assets.thermofisher.com/TFS-Assets/LSG/manuals/tac_user_manual.pdf">https://assets.thermofisher.com/TFS-Assets/LSG/manuals/tac_user_manual.pdf</ext-link>). mRNA expression analysis was performed using Significance Analysis of Microarrays (SAM) in R (<ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.r-project.org/</ext-link>). Probes with average log2 &#x0003c; 5.5 in both comparison groups, and probes lacking annotation (<ext-link ext-link-type="uri" xlink:href="http://ftp.broadinstitute.org/pub/gsea/annotations/Clariom_D_Human.r1.chip">ftp.broadinstitute.org/pub/gsea/annotations/Clariom_D_Human.r1.chip</ext-link>) were removed. For each gene, the probeset with the maximum average expression was retained. Two class unpaired SAM was run with the following parameters: nperms = 100, min.foldchange = 0.1, and nvals = 50.</p></sec></sec><sec id="sec013"><title>Gene expression analysis of <italic>TRIM28</italic>-mutant WT</title><p>Paired-end fastq files were aligned to hg19 using HISAT2 [<xref rid="pone.0208936.ref065" ref-type="bibr">65</xref>]. Aligned reads were counted using htseq-count with the UCSC transcriptome gtf file as a reference [<xref rid="pone.0208936.ref066" ref-type="bibr">66</xref>]. Differential mRNA gene expression was determined with the DESeq2 package for R (<ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.r-project.org/</ext-link>) using default parameters. Gene Set Enrichment Analysis 3.0 (GSEA, [<xref rid="pone.0208936.ref067" ref-type="bibr">67</xref>]) was performed using a local gmt file containing separate gene lists corresponding to the up- or down-regulated genes from <xref ref-type="supplementary-material" rid="pone.0208936.s008">S3 Table</xref> in [<xref rid="pone.0208936.ref022" ref-type="bibr">22</xref>]. The preranked gene list was prepared by removing transcripts with basemean &#x0003c; 10 and calculating and ranking the genes based on the&#x02013;log10 of the DESeq2 p-value from the DESeq2 comparison of <italic>TRIM28</italic>-mutant WT versus <italic>TRIM28</italic>-non-mutant WT. The following GSEA parameters were used: 1000 permutations and classic enrichment statistic.</p><p>For transposable element (TE) expression analysis, aligned reads that overlapped with TEs were counted by using htseq-count with a custom hg19 gtf file (<ext-link ext-link-type="uri" xlink:href="http://labshare.cshl.edu/shares/mhammelllab/www-data/TEToolkit/TE_GTF/">http://labshare.cshl.edu/shares/mhammelllab/www-data/TEToolkit/TE_GTF/</ext-link>), which provides a unique ID for each TE annotation. Transcripts with an average read count &#x0003e;5 in all samples were retained. Differential expression analysis was performed using the DESeq2 package, as described above. To detect TEs within the TRIM28 knock-down clones, quantitative RT-PCR was performed for four endogenous retroviruses (ERVs) differentially expressed in <italic>TRIM28</italic> mutant TARGET tumors (adjusted q &#x0003c; 0.05) for which primers lacking high self-complementarity could be generated (See <xref ref-type="supplementary-material" rid="pone.0208936.s009">S1 File</xref> for primers and conditions).</p></sec></sec><sec sec-type="supplementary-material" id="sec014"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0208936.s001"><label>S1 Fig</label><caption><title>Sanger sequencing of TRIM28 variants.</title><p>(a) Internal tandem duplication in Exon 1 of <italic>TRIM28</italic> (g.chr19:g.59056439_59056440insCGGCGGGG); (b) Single nucleotide polymorphism (SNP) in splice-site between Exon 1 and 2 of <italic>TRIM28</italic> (g.chr19:59056466T&#x0003e;G); (c) SNP in splice-site between Exon 5 and 6 of <italic>TRIM28</italic> (g.chr19:59059081G&#x0003e;A).</p><p>(TIF)</p></caption><media xlink:href="pone.0208936.s001.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0208936.s002"><label>S2 Fig</label><caption><title>Sashimi plot of TRIM28 exon 5-exon 6 boundary in PAKVET.</title><p>RNAseq paired-end fastq files were processed using FASTQGroomer, mapped to the human reference genome (hg19) using TopHat, and Sashimi plots were generated from the aligned bam file in IGV. The plot demonstrates the effect of the g.59059081G&#x0003e;A DNA splice-site variant on RNA.</p><p>(TIF)</p></caption><media xlink:href="pone.0208936.s002.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0208936.s003"><label>S3 Fig</label><caption><title><italic>TRIM28</italic> gene expression in CRISPR clones.</title><p>TRIM28 mRNA levels were evaluated in the parent HEK293 cell line and in selected CRISPR clones by qPCR using the TRIM28 TaqMan Gene Expression Assay from ThermoFisher. TRIM28 expression was normalized to <italic>GAPDH</italic> and is presented as the relative quantitative (RQ) value compared to HEK293 parent cells. Reduced mRNA levels were observed in CRISPR clones d, e and l, and wild-type mRNA levelswere observed in CRISPR clones f and o in comparison to HEK293 parent cells. Error bars represent the standard deviation of two PCR replicates.</p><p>(TIF)</p></caption><media xlink:href="pone.0208936.s003.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0208936.s004"><label>S4 Fig</label><caption><title>TRIM28 protein expression in CRISPR clones.</title><p>TRIM28 protein levels were evaluated in the parent HEK293 cell line and in selected CRISPR clones by western blotting using a polyclonal TRIM28 antibody from Abcam. The protein content was quantified in cell lysates by BCA, and equal amounts were loaded per lane; B-ACTIN was run on the same blot as an equal loading control. Reduced TRIM28 protein levels were observed in CRISPR clones d, L, and e, whereas protein levels were similar in HEK293 parent cells and clones f and o.</p><p>(TIF)</p></caption><media xlink:href="pone.0208936.s004.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0208936.s005"><label>S5 Fig</label><caption><title><italic>TRIM28</italic> genotype in CRISPR clones.</title><p>Genomic DNA was isolated from the parent HEK293 cell line and selected CRISPR clones and the TRIM28 CRISPR target region was amplified for Sanger sequencing. A single base pair insertion resulting in a frameshift change was found in CRISPR clones d, L, and e, whereas the genotype was normal in HEK293 parent cells and clones f and o.</p><p>(TIF)</p></caption><media xlink:href="pone.0208936.s005.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0208936.s006"><label>S1 Table</label><caption><title>Copy number variants and loss of heterozygosity (LOH) identified in S1 favorable histology Wilms tumors.</title><p>Copy number and LOH analysis were performed in 5 S1 tumors using Nexus 6.1 (BioDiscovery) according to the parameters described in <xref ref-type="supplementary-material" rid="pone.0208936.s009">S1 File</xref>. Copy number and LOH events were filtered to include only those that occurred in &#x0003e; 2 samples.</p><p>(PDF)</p></caption><media xlink:href="pone.0208936.s006.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0208936.s007"><label>S2 Table</label><caption><title>Differentially expressed genes in TRIM28-mutant Wilms tumors.</title><p>RNAseq gene transcript data from 3 <italic>TRIM28</italic>-mutant WTs was compared to six randomly selected <italic>TRIM28</italic>-wildtype WTs using DESeq2 as described in the Methods. The data were filtered to include transcripts with adjusted p-value &#x0003c; 0.01.</p><p>(PDF)</p></caption><media xlink:href="pone.0208936.s007.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0208936.s008"><label>S3 Table</label><caption><title>Differentially expressed TEs in TRIM28-mutant Wilms tumors.</title><p>RNAseq transposable element data from 3 <italic>TRIM28</italic>-mutant WTs was compared to six randomly selected <italic>TRIM28</italic>-wildtype WTs using DESeq2 as described in the Methods. The data were filtered to include TEs with adjusted p-value &#x0003c; 0.001.</p><p>(PDF)</p></caption><media xlink:href="pone.0208936.s008.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0208936.s009"><label>S1 File</label><caption><title>Supplemental methods.</title><p>(DOCX)</p></caption><media xlink:href="pone.0208936.s009.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>This work would not be possible without the dedication of all the experts within the many disciplines both at the local institutions and centrally within the Children&#x02019;s Oncology Group. They enable the coordination and accurate annotation required for the therapeutic and biology protocols that form the basis for these studies.</p></ack><ref-list><title>References</title><ref id="pone.0208936.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Dressler</surname><given-names>GR</given-names></name>. <article-title>The cellular basis of kidney development</article-title>. <source>Annu Rev Cell Dev Biol</source>. <year>2006</year>; <volume>22</volume>: <fpage>509</fpage>&#x02013;<lpage>29</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev.cellbio.22.010305.104340">10.1146/annurev.cellbio.22.010305.104340</ext-link>
<?supplied-pmid 16822174?><pub-id pub-id-type="pmid">16822174</pub-id></mixed-citation></ref><ref id="pone.0208936.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Hohenstein</surname><given-names>P</given-names></name>, <name><surname>Pritchard-Jones</surname><given-names>K</given-names></name>, <name><surname>Charlton</surname><given-names>J</given-names></name>. <article-title>The yin and yang of kidney development and Wilms&#x02019; tumors</article-title>. <source>Genes Dev</source>. <year>2015</year>; <volume>29</volume>(<issue>5</issue>):<fpage>467</fpage>&#x02013;<lpage>82</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/gad.256396.114">10.1101/gad.256396.114</ext-link>
<?supplied-pmid 25737276?><pub-id pub-id-type="pmid">25737276</pub-id></mixed-citation></ref><ref id="pone.0208936.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Rivera</surname><given-names>M.N.</given-names></name> and <name><surname>Haber</surname><given-names>D.A.</given-names></name>
<article-title>Wilms tumour: connecting tumorigenesis and organ development in the kidney</article-title>. <source>Nat. Rev. Cancer</source>. <year>2005</year>; <volume>9</volume>: <fpage>699</fpage>&#x02013;<lpage>712</lpage>.</mixed-citation></ref><ref id="pone.0208936.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Gadd</surname><given-names>S</given-names></name>, <name><surname>Huff</surname><given-names>V</given-names></name>, <name><surname>Huang</surname><given-names>C-C</given-names></name>, <name><surname>Ruteshouser</surname><given-names>EC</given-names></name>, <name><surname>Dome</surname><given-names>JS</given-names></name>, <name><surname>Grundy</surname><given-names>PE</given-names></name>, <etal>et al</etal>
<article-title>Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children&#x02019;s Oncology Group Study</article-title>. <source>Neoplasia N Y N</source>. <year>2012</year>; <volume>14</volume>(<issue>8</issue>): <fpage>742</fpage>&#x02013;<lpage>56</lpage>.</mixed-citation></ref><ref id="pone.0208936.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Gadd</surname><given-names>S</given-names></name>, <name><surname>Huff</surname><given-names>V</given-names></name>, <name><surname>Walz</surname><given-names>AL</given-names></name>, <name><surname>Ooms</surname><given-names>AHAG</given-names></name>, <name><surname>Armstrong</surname><given-names>AE</given-names></name>, <name><surname>Gerhard</surname><given-names>DS</given-names></name>, <etal>et al</etal>
<article-title>A Children&#x02019;s Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor</article-title>. <source>Nat Genet</source>. <year>2017</year>; <volume>49</volume>(<issue>10</issue>):<fpage>1487</fpage>&#x02013;<lpage>94</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.3940">10.1038/ng.3940</ext-link>
<?supplied-pmid 28825729?><pub-id pub-id-type="pmid">28825729</pub-id></mixed-citation></ref><ref id="pone.0208936.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Torrezan</surname><given-names>GT</given-names></name>, <name><surname>Ferreira</surname><given-names>EN</given-names></name>, <name><surname>Nakahata</surname><given-names>AM</given-names></name>, <name><surname>Barros</surname><given-names>BDF</given-names></name>, <name><surname>Castro</surname><given-names>MTM</given-names></name>, <name><surname>Correa</surname><given-names>BR</given-names></name>, <etal>et al</etal>
<article-title>Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour</article-title>. <source>Nat Commun</source>. <year>2014</year>; <volume>9</volume>(<issue>5</issue>):<fpage>4039</fpage>.</mixed-citation></ref><ref id="pone.0208936.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Wegert</surname><given-names>J</given-names></name>, <name><surname>Ishaque</surname><given-names>N</given-names></name>, <name><surname>Vardapour</surname><given-names>R</given-names></name>, <name><surname>Ge&#x000f6;rg</surname><given-names>C</given-names></name>, <name><surname>Gu</surname><given-names>Z</given-names></name>, <name><surname>Bieg</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors</article-title>. <source>Cancer Cell</source>. <year>2015</year>; <volume>27</volume>(<issue>2</issue>):<fpage>298</fpage>&#x02013;<lpage>311</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ccell.2015.01.002">10.1016/j.ccell.2015.01.002</ext-link>
<?supplied-pmid 25670083?><pub-id pub-id-type="pmid">25670083</pub-id></mixed-citation></ref><ref id="pone.0208936.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Rakheja</surname><given-names>D</given-names></name>, <name><surname>Chen</surname><given-names>KS</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Shukla</surname><given-names>AA</given-names></name>, <name><surname>Schmid</surname><given-names>V</given-names></name>, <name><surname>Chang</surname><given-names>T-C</given-names></name>, <etal>et al</etal>
<article-title>Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours</article-title>. <source>Nat Commun</source>. <year>2014</year>; <volume>5</volume>(<issue>2</issue>):<fpage>4802</fpage>.</mixed-citation></ref><ref id="pone.0208936.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Walz</surname><given-names>AL</given-names></name>, <name><surname>Ooms</surname><given-names>A</given-names></name>, <name><surname>Gadd</surname><given-names>S</given-names></name>, <name><surname>Gerhard</surname><given-names>DS</given-names></name>, <name><surname>Smith</surname><given-names>MA</given-names></name>, <name><surname>Guidry Auvil</surname><given-names>JM</given-names></name>, <etal>et al</etal>
<article-title>Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors</article-title>. <source>Cancer Cell</source>. <year>2015</year>; <volume>27</volume>(<issue>2</issue>):<fpage>286</fpage>&#x02013;<lpage>97</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ccell.2015.01.003">10.1016/j.ccell.2015.01.003</ext-link>
<?supplied-pmid 25670082?><pub-id pub-id-type="pmid">25670082</pub-id></mixed-citation></ref><ref id="pone.0208936.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Ooms</surname><given-names>AH</given-names></name>, <name><surname>Gadd</surname><given-names>S</given-names></name>, <name><surname>Gerhard</surname><given-names>DS</given-names></name>, <name><surname>Smith</surname><given-names>MA</given-names></name>, <name><surname>Guidry Auvil</surname><given-names>JM</given-names></name>, <name><surname>Meerzaman</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group</article-title>. <source>Clin Cancer Res</source>. <year>2016</year>; <volume>22</volume>(<issue>22</issue>):<fpage>5582</fpage>&#x02013;<lpage>91</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1078-0432.CCR-16-0985">10.1158/1078-0432.CCR-16-0985</ext-link>
<?supplied-pmid 27702824?><pub-id pub-id-type="pmid">27702824</pub-id></mixed-citation></ref><ref id="pone.0208936.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Perlman</surname><given-names>EJ</given-names></name>, <name><surname>Gadd</surname><given-names>S</given-names></name>, <name><surname>Arold</surname><given-names>ST</given-names></name>, <name><surname>Radhakrishnan</surname><given-names>A</given-names></name>, <name><surname>Gerhard</surname><given-names>DS</given-names></name>, <name><surname>Jennings</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours</article-title>. <source>Nat Commun</source>. <year>2015</year>; <volume>4</volume>(<issue>6</issue>):<fpage>10013</fpage>.</mixed-citation></ref><ref id="pone.0208936.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Cammas</surname><given-names>F</given-names></name>, <name><surname>Mark</surname><given-names>M</given-names></name>, <name><surname>Dolle</surname><given-names>P</given-names></name>, <name><surname>Dierich</surname><given-names>A</given-names></name>, <name><surname>Chambon</surname><given-names>P</given-names></name>, <name><surname>Losson</surname><given-names>R</given-names></name>. <article-title>Mice lacking the transcriptional corepressor TIF1beta are defective in early postimplantation development</article-title>. <source>Development</source>. <year>2000</year>; <volume>127</volume>: <fpage>2955</fpage>&#x02013;<lpage>63</lpage>. <?supplied-pmid 10851139?><pub-id pub-id-type="pmid">10851139</pub-id></mixed-citation></ref><ref id="pone.0208936.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Halliday</surname><given-names>BJ</given-names></name>, <name><surname>Fukuzawa</surname><given-names>R</given-names></name>, <name><surname>Markie</surname><given-names>DM</given-names></name>, <name><surname>Grundy</surname><given-names>RG</given-names></name>, <name><surname>Ludgate</surname><given-names>JL</given-names></name>, <name><surname>Black</surname><given-names>MA</given-names></name>, <etal>et al</etal>
<article-title>Germline mutations and somatic inactivation of TRIM28 in Wilms tumour</article-title>. <source>PLoS Genet</source>. <year>2018</year>; <volume>14</volume>(<issue>6</issue>):<fpage>e1007399</fpage>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pgen.1007399">10.1371/journal.pgen.1007399</ext-link>
<?supplied-pmid 29912901?><pub-id pub-id-type="pmid">29912901</pub-id></mixed-citation></ref><ref id="pone.0208936.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Gooskens</surname><given-names>SL</given-names></name>, <name><surname>Gadd</surname><given-names>S</given-names></name>, <name><surname>Guidry Auvil</surname><given-names>JM</given-names></name>, <name><surname>Gerhard</surname><given-names>DS</given-names></name>, <name><surname>Khan</surname><given-names>J</given-names></name>, <name><surname>Patidar</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>TCF21 hypermethylation in genetically quiescent clear cell sarcoma of the kidney</article-title>. <source>Oncotarget</source>. <year>2015</year>; <volume>6</volume>(<issue>18</issue>):<fpage>15828</fpage>&#x02013;<lpage>41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.4682">10.18632/oncotarget.4682</ext-link></comment>
<?supplied-pmid 26158413?><pub-id pub-id-type="pmid">26158413</pub-id></mixed-citation></ref><ref id="pone.0208936.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>O&#x02019;Geen</surname><given-names>H</given-names></name>, <name><surname>Squazzo</surname><given-names>SL</given-names></name>, <name><surname>Iyengar</surname><given-names>S</given-names></name>, <name><surname>Blahnik</surname><given-names>K</given-names></name>, <name><surname>Rinn</surname><given-names>JL</given-names></name>, <name><surname>Chang</surname><given-names>HY</given-names></name>, <etal>et al</etal>
<article-title>Genome-wide analysis of KAP1 binding suggests autoregulation of KRAB-ZNFs</article-title>. <source>PLoS Genet</source>. <year>2007</year>; <month>6</month>;<volume>3</volume>(<issue>6</issue>):<fpage>e89</fpage>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pgen.0030089">10.1371/journal.pgen.0030089</ext-link>
<?supplied-pmid 17542650?><pub-id pub-id-type="pmid">17542650</pub-id></mixed-citation></ref><ref id="pone.0208936.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Schmitt</surname><given-names>K</given-names></name>, <name><surname>Guo</surname><given-names>K</given-names></name>, <name><surname>Santiago</surname><given-names>ML</given-names></name>, <name><surname>Stephens</surname><given-names>EB</given-names></name>. <article-title>Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer</article-title>. <source>J Gen Virol</source>. <year>2016</year>; <volume>97</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>17</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1099/jgv.0.000320">10.1099/jgv.0.000320</ext-link>
<?supplied-pmid 26489798?><pub-id pub-id-type="pmid">26489798</pub-id></mixed-citation></ref><ref id="pone.0208936.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Rowe</surname><given-names>HM</given-names></name>, <name><surname>Jakobsson</surname><given-names>J</given-names></name>, <name><surname>Mesnard</surname><given-names>D</given-names></name>, <name><surname>Rougemont</surname><given-names>J</given-names></name>, <name><surname>Reynard</surname><given-names>S</given-names></name>, <name><surname>Aktas</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>KAP1 controls endogenous retroviruses in embryonic stem cells</article-title>. <source>Nature</source>. <year>2010</year>; <volume>463</volume>(<issue>7278</issue>):<fpage>237</fpage>&#x02013;<lpage>40</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature08674">10.1038/nature08674</ext-link>
<?supplied-pmid 20075919?><pub-id pub-id-type="pmid">20075919</pub-id></mixed-citation></ref><ref id="pone.0208936.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Rowe</surname><given-names>HM</given-names></name>, <name><surname>Friedli</surname><given-names>M</given-names></name>, <name><surname>Offner</surname><given-names>S</given-names></name>, <name><surname>Verp</surname><given-names>S</given-names></name>, <name><surname>Mesnard</surname><given-names>D</given-names></name>, <name><surname>Marquis</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>De novo DNA methylation of endogenous retroviruses is shaped by KRAB-ZFPs/KAP1 and ESET</article-title>. <source>Development</source>. <year>2013</year>; <volume>140</volume>(<issue>3</issue>):<fpage>519</fpage>&#x02013;<lpage>29</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/dev.087585">10.1242/dev.087585</ext-link>
<?supplied-pmid 23293284?><pub-id pub-id-type="pmid">23293284</pub-id></mixed-citation></ref><ref id="pone.0208936.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Fasching</surname><given-names>L</given-names></name>, <name><surname>Kapopoulou</surname><given-names>A</given-names></name>, <name><surname>Sachdeva</surname><given-names>R</given-names></name>, <name><surname>Petri</surname><given-names>R</given-names></name>, <name><surname>J&#x000f6;nsson</surname><given-names>ME</given-names></name>, <name><surname>M&#x000e4;nne</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>TRIM28 represses transcription of endogenous retroviruses in neural progenitor cells</article-title>. <source>Cell Rep</source>. <year>2015</year>; <volume>10</volume>(<issue>1</issue>):<fpage>20</fpage>&#x02013;<lpage>8</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.celrep.2014.12.004">10.1016/j.celrep.2014.12.004</ext-link>
<?supplied-pmid 25543143?><pub-id pub-id-type="pmid">25543143</pub-id></mixed-citation></ref><ref id="pone.0208936.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Lukic</surname><given-names>S</given-names></name>, <name><surname>Nicolas</surname><given-names>J-C</given-names></name>, <name><surname>Levine</surname><given-names>AJ</given-names></name>. <article-title>The diversity of zinc-finger genes on human chromosome 19 provides an evolutionary mechanism for defense against inherited endogenous retroviruses</article-title>. <source>Cell Death Differ</source>. <year>2014</year>; <volume>21</volume>(<issue>3</issue>):<fpage>381</fpage>&#x02013;<lpage>7</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cdd.2013.150">10.1038/cdd.2013.150</ext-link>
<?supplied-pmid 24162661?><pub-id pub-id-type="pmid">24162661</pub-id></mixed-citation></ref><ref id="pone.0208936.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Tao</surname><given-names>Y</given-names></name>, <name><surname>Yen</surname><given-names>MR</given-names></name>, <name><surname>Chitiashvili</surname><given-names>T</given-names></name>, <name><surname>Nakano</surname><given-names>H</given-names></name>, <name><surname>Kim</surname><given-names>R</given-names></name>, <name><surname>Hosohama</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>TRIM28-regulated transposon repression is required for human germline competency and not primed or na&#x000ef;ve human pluripotency</article-title>. <source>Stem Cell Reports</source>. <year>2018</year>; <volume>10</volume>(<issue>1</issue>):<fpage>243</fpage>&#x02013;<lpage>56</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.stemcr.2017.11.020">10.1016/j.stemcr.2017.11.020</ext-link>
<?supplied-pmid 29290627?><pub-id pub-id-type="pmid">29290627</pub-id></mixed-citation></ref><ref id="pone.0208936.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Iyengar</surname><given-names>S1</given-names></name>, <name><surname>Ivanov</surname><given-names>AV</given-names></name>, <name><surname>Jin</surname><given-names>VX</given-names></name>, <name><surname>Rauscher</surname><given-names>FJ 3rd</given-names></name>, <name><surname>Farnham</surname><given-names>PJ</given-names></name>.<article-title>Functional analysis of KAP1 genomic recruitment</article-title>. <source>Mol Cell Biol</source>. <year>2011</year>; <volume>31</volume>(<issue>9</issue>):<fpage>1833</fpage>&#x02013;<lpage>47</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/MCB.01331-10">10.1128/MCB.01331-10</ext-link>
<?supplied-pmid 21343339?><pub-id pub-id-type="pmid">21343339</pub-id></mixed-citation></ref><ref id="pone.0208936.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Friedman</surname><given-names>JR</given-names></name>, <name><surname>Fredericks</surname><given-names>WJ</given-names></name>, <name><surname>Jensen</surname><given-names>DE</given-names></name>, <name><surname>Speicher</surname><given-names>DW</given-names></name>, <name><surname>Huang</surname><given-names>XP</given-names></name>, <name><surname>Neilson</surname><given-names>EG</given-names></name>, <etal>et al</etal>
<article-title>KAP-1, a novel corepressor for the highly conserved KRAB repression domain</article-title>. <source>Genes Dev</source>. <year>1996</year>; <volume>10</volume>(<issue>16</issue>):<fpage>2067</fpage>&#x02013;<lpage>78</lpage>. <?supplied-pmid 8769649?><pub-id pub-id-type="pmid">8769649</pub-id></mixed-citation></ref><ref id="pone.0208936.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>SS</given-names></name>, <name><surname>Chen</surname><given-names>YM</given-names></name>, <name><surname>O'Leary</surname><given-names>E</given-names></name>, <name><surname>Witzgall</surname><given-names>R</given-names></name>, <name><surname>Vidal</surname><given-names>M</given-names></name>, <name><surname>Bonventre</surname><given-names>JV</given-names></name>. <article-title>A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1996</year>; <volume>93</volume>(<issue>26</issue>):<fpage>15299</fpage>&#x02013;<lpage>304</lpage>. <?supplied-pmid 8986806?><pub-id pub-id-type="pmid">8986806</pub-id></mixed-citation></ref><ref id="pone.0208936.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Le Douarin</surname><given-names>B</given-names></name>, <name><surname>Nielsen</surname><given-names>AL</given-names></name>, <name><surname>Garnier</surname><given-names>JM</given-names></name>, <name><surname>Ichinose</surname><given-names>H</given-names></name>, <name><surname>Jeanmougin</surname><given-names>F</given-names></name>, <name><surname>Losson</surname><given-names>R</given-names></name>, <name><surname>Chambon</surname><given-names>P</given-names></name>. <article-title>A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors</article-title>. <source>EMBO J</source>. <year>1996</year>; <volume>15</volume>:<fpage>6701</fpage>&#x02013;<lpage>15</lpage>. <?supplied-pmid 8978696?><pub-id pub-id-type="pmid">8978696</pub-id></mixed-citation></ref><ref id="pone.0208936.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Damineni</surname><given-names>S</given-names></name>, <name><surname>Balaji</surname><given-names>SA</given-names></name>, <name><surname>Shettar</surname><given-names>A</given-names></name>, <name><surname>Nayanala</surname><given-names>S</given-names></name>, <name><surname>Kumar</surname><given-names>N</given-names></name>, <name><surname>Kruthika</surname><given-names>BS</given-names></name>, <etal>et al</etal>
<article-title>Expression of tripartite motif-containing protein 28 in primary breast carcinoma predicts metastasis and is involved in the stemness, chemoresistance, and tumor growth</article-title>. <source>Tumour Biol J Int Soc Oncodevelopmental Biol Med</source>. <year>2017</year>
<month>4</month>;<volume>9</volume>(<issue>4</issue>):<fpage>1010428317695919</fpage>.</mixed-citation></ref><ref id="pone.0208936.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Ho</surname><given-names>J</given-names></name>, <name><surname>Kong</surname><given-names>JWF</given-names></name>, <name><surname>Choong</surname><given-names>LY</given-names></name>, <name><surname>Loh</surname><given-names>MCS</given-names></name>, <name><surname>Toy</surname><given-names>W</given-names></name>, <name><surname>Chong</surname><given-names>PK</given-names></name>, <etal>et al</etal>
<article-title>Novel breast cancer metastasis-associated proteins</article-title>. <source>J Proteome Res</source>. <year>2009</year>; <volume>8</volume>(<issue>2</issue>):<fpage>583</fpage>&#x02013;<lpage>94</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/pr8007368">10.1021/pr8007368</ext-link>
<?supplied-pmid 19086899?><pub-id pub-id-type="pmid">19086899</pub-id></mixed-citation></ref><ref id="pone.0208936.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>C</given-names></name>, <name><surname>Zhan</surname><given-names>L</given-names></name>, <name><surname>Jiang</surname><given-names>J</given-names></name>, <name><surname>Pan</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Li</surname><given-names>X</given-names></name>, <etal>et al</etal>
<article-title>KAP-1 is overexpressed and correlates with increased metastatic ability and tumorigenicity in pancreatic cancer</article-title>. <source>Med Oncol Northwood Lond Engl</source>. <year>2014</year>; <volume>31</volume>(<issue>7</issue>):<fpage>25</fpage>.</mixed-citation></ref><ref id="pone.0208936.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Qi</surname><given-names>ZX</given-names></name>, <name><surname>Cai</surname><given-names>JJ</given-names></name>, <name><surname>Chen</surname><given-names>LC</given-names></name>, <name><surname>Yue</surname><given-names>Q</given-names></name>, <name><surname>Gong</surname><given-names>Y</given-names></name>, <name><surname>Yao</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>TRIM28 as an independent prognostic marker plays critical roles in glioma progression</article-title>. <source>J Neurooncol</source>. <year>2016</year>; <volume>126</volume>(<issue>1</issue>):<fpage>19</fpage>&#x02013;<lpage>26</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11060-015-1897-8">10.1007/s11060-015-1897-8</ext-link>
<?supplied-pmid 26476730?><pub-id pub-id-type="pmid">26476730</pub-id></mixed-citation></ref><ref id="pone.0208936.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Czerwi&#x00144;ska</surname><given-names>P</given-names></name>, <name><surname>Mazurek</surname><given-names>S</given-names></name>, <name><surname>Wiznerowicz</surname><given-names>M</given-names></name>. <article-title>The complexity of TRIM28 contribution to cancer</article-title>. <source>J Biomed Sci</source>. <year>2017</year>; <volume>24</volume>(<issue>1</issue>):<fpage>63</fpage>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12929-017-0374-4">10.1186/s12929-017-0374-4</ext-link>
<?supplied-pmid 28851455?><pub-id pub-id-type="pmid">28851455</pub-id></mixed-citation></ref><ref id="pone.0208936.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Schultz</surname><given-names>DC</given-names></name>, <name><surname>Ayyanathan</surname><given-names>K</given-names></name>, <name><surname>Negorev</surname><given-names>D</given-names></name>, <name><surname>Maul</surname><given-names>GG</given-names></name>, <name><surname>Rauscher</surname><given-names>3rd FJ</given-names></name>. <article-title>SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins</article-title>. <source>Genes Dev</source>. <year>2002</year>; <volume>16</volume>:<fpage>919</fpage>&#x02013;<lpage>32</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/gad.973302">10.1101/gad.973302</ext-link>
<?supplied-pmid 11959841?><pub-id pub-id-type="pmid">11959841</pub-id></mixed-citation></ref><ref id="pone.0208936.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Brattas</surname><given-names>PL</given-names></name>, <name><surname>Jonsson</surname><given-names>ME</given-names></name>, <name><surname>Fasching</surname><given-names>L</given-names></name>, <name><surname>Nelander Wahlestedt</surname><given-names>J</given-names></name>, <name><surname>Shahsavani</surname><given-names>M</given-names></name>, <name><surname>Falk</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>TRIM28 controls a gene regulatory network based on endogenous retroviruses in human neural progenitor cells</article-title>. <source>Cell Rep</source>. <year>2017</year>; <volume>18</volume>:<fpage>1</fpage>&#x02013;<lpage>11</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.celrep.2016.12.010">10.1016/j.celrep.2016.12.010</ext-link>
<?supplied-pmid 28052240?><pub-id pub-id-type="pmid">28052240</pub-id></mixed-citation></ref><ref id="pone.0208936.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Wolf</surname><given-names>D</given-names></name>, <name><surname>Cammas</surname><given-names>F</given-names></name>, <name><surname>Losson</surname><given-names>R</given-names></name>, <name><surname>Goff</surname><given-names>SP</given-names></name>. <article-title>Primer binding site-dependent restriction of murine leukemia virus requires HP1 binding by TRIM28</article-title>. <source>J Virol</source>. <year>2008</year>; <volume>82</volume>:<fpage>4675</fpage>&#x02013;<lpage>79</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.02445-07">10.1128/JVI.02445-07</ext-link>
<?supplied-pmid 18287239?><pub-id pub-id-type="pmid">18287239</pub-id></mixed-citation></ref><ref id="pone.0208936.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Wolf</surname><given-names>D</given-names></name>, <name><surname>Goff</surname><given-names>SP</given-names></name>. <article-title>TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells</article-title>. <source>Cell</source>. <year>2007</year>; <volume>131</volume>:<fpage>46</fpage>&#x02013;<lpage>57</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2007.07.026">10.1016/j.cell.2007.07.026</ext-link>
<?supplied-pmid 17923087?><pub-id pub-id-type="pmid">17923087</pub-id></mixed-citation></ref><ref id="pone.0208936.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Castro-Diaz</surname><given-names>N</given-names></name>, <name><surname>Ecco</surname><given-names>G</given-names></name>, <name><surname>Coluccio</surname><given-names>A</given-names></name>, <name><surname>Kapopoulou</surname><given-names>A</given-names></name>, <name><surname>Yazdanpanah</surname><given-names>B</given-names></name>, <name><surname>Friedli</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Evolutionally dynamic L1 regulation in embryonic stem cells</article-title>. <source>Genes Dev</source>. <year>2014</year>;<volume>28</volume>: <fpage>1397</fpage>&#x02013;<lpage>1409</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/gad.241661.114">10.1101/gad.241661.114</ext-link>
<?supplied-pmid 24939876?><pub-id pub-id-type="pmid">24939876</pub-id></mixed-citation></ref><ref id="pone.0208936.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Jacobs</surname><given-names>FM</given-names></name>, <name><surname>Greenberg</surname><given-names>D</given-names></name>, <name><surname>Nguyen</surname><given-names>N</given-names></name>, <name><surname>Haeussler</surname><given-names>M</given-names></name>, <name><surname>Ewing</surname><given-names>AD</given-names></name>, <name><surname>Katzman</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>An evolutionary arms race between KRAB zinc-finger genes ZNF91/93 and SVA/L1 retrotransposons</article-title>. <source>Nature</source>. <year>2014</year>; <volume>516</volume>:<fpage>242</fpage>&#x02013;<lpage>45</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature13760">10.1038/nature13760</ext-link>
<?supplied-pmid 25274305?><pub-id pub-id-type="pmid">25274305</pub-id></mixed-citation></ref><ref id="pone.0208936.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Rowe</surname><given-names>HM</given-names></name>, <name><surname>Kapopoulou</surname><given-names>A</given-names></name>, <name><surname>Corsinotti</surname><given-names>A</given-names></name>, <name><surname>Fasching</surname><given-names>L</given-names></name>, <name><surname>Macfarlan</surname><given-names>TS</given-names></name>, <name><surname>Tarabay</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>TRIM28 repression of retrotransposon-based enhancers is necessary to preserve transcriptional dynamics in embryonic stem cells</article-title>. <source>Genome Res</source>. <year>2013</year>; <volume>23</volume>(<issue>3</issue>):<fpage>452</fpage>&#x02013;<lpage>61</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/gr.147678.112">10.1101/gr.147678.112</ext-link>
<?supplied-pmid 23233547?><pub-id pub-id-type="pmid">23233547</pub-id></mixed-citation></ref><ref id="pone.0208936.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Turelli</surname><given-names>P</given-names></name>, <name><surname>Castro-Diaz</surname><given-names>N</given-names></name>, <name><surname>Marzetta</surname><given-names>F</given-names></name>, <name><surname>Kapopoulou</surname><given-names>A</given-names></name>, <name><surname>Raclot</surname><given-names>C</given-names></name>, <name><surname>Duc</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Interplay of TRIM28 and DNA methylation in controlling human endogenous retroelements</article-title>. <source>Genome Res</source>. <year>2014</year>; <volume>24</volume>:<fpage>1260</fpage>&#x02013;<lpage>70</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/gr.172833.114">10.1101/gr.172833.114</ext-link>
<?supplied-pmid 24879559?><pub-id pub-id-type="pmid">24879559</pub-id></mixed-citation></ref><ref id="pone.0208936.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Imbeault</surname><given-names>M</given-names></name>, <name><surname>Helleboid</surname><given-names>PY</given-names></name>, <name><surname>Trono</surname><given-names>D</given-names></name>. <article-title>KRAB zinc-finger proteins contribute to the evolution of gene regulatory networks</article-title>. <source>Nature</source>. <year>2017</year>; <volume>543</volume>(<issue>7646</issue>):<fpage>550</fpage>&#x02013;<lpage>4</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature21683">10.1038/nature21683</ext-link>
<?supplied-pmid 28273063?><pub-id pub-id-type="pmid">28273063</pub-id></mixed-citation></ref><ref id="pone.0208936.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Najafabadi</surname><given-names>HS</given-names></name>, <name><surname>Mnaimneh</surname><given-names>S</given-names></name>, <name><surname>Schmitges</surname><given-names>FW</given-names></name>, <name><surname>Garton</surname><given-names>M</given-names></name>, <name><surname>Lam</surname><given-names>KN</given-names></name>, <name><surname>Yang</surname><given-names>A</given-names></name>, <etal>et al</etal>, <article-title>C2H2 zinc finger proteins greatly expand the human regulatory lexicon</article-title>. <source>Nat. Biotechnol</source>. <year>2015</year>; <volume>33</volume>:<fpage>555</fpage>&#x02013;<lpage>62</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nbt.3128">10.1038/nbt.3128</ext-link>
<?supplied-pmid 25690854?><pub-id pub-id-type="pmid">25690854</pub-id></mixed-citation></ref><ref id="pone.0208936.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Ellis</surname><given-names>J</given-names></name>, <name><surname>Hotta</surname><given-names>A</given-names></name>, <name><surname>Rastegar</surname><given-names>M</given-names></name>. <article-title>Retrovirus silencing by an epigenetic TRIM</article-title>. <source>Cell</source>. <year>2007</year>; <volume>131</volume>:<fpage>13</fpage>&#x02013;<lpage>14</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2007.09.029">10.1016/j.cell.2007.09.029</ext-link>
<?supplied-pmid 17923079?><pub-id pub-id-type="pmid">17923079</pub-id></mixed-citation></ref><ref id="pone.0208936.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Wiznerowicz</surname><given-names>M</given-names></name>, <name><surname>Jakobsson</surname><given-names>J</given-names></name>, <name><surname>Szulc</surname><given-names>J</given-names></name>, <name><surname>Liao</surname><given-names>S</given-names></name>, <name><surname>Quazzola</surname><given-names>A</given-names></name>, <name><surname>Beermann</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>The Kruppel-associated box repressor domain can trigger de novo promoter methylation during mouse early embryogenesis</article-title>. <source>J Biol Chem</source>. <year>2007</year>; <volume>282</volume>:<fpage>34535</fpage>&#x02013;<lpage>41</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M705898200">10.1074/jbc.M705898200</ext-link>
<?supplied-pmid 17893143?><pub-id pub-id-type="pmid">17893143</pub-id></mixed-citation></ref><ref id="pone.0208936.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Rowe</surname><given-names>HM</given-names></name>, <name><surname>Trono</surname><given-names>D</given-names></name>. <article-title>Dynamic control of endogenous retroviruses during development</article-title>. <source>Virology</source>. <year>2011</year>; <volume>411</volume>:<fpage>273</fpage>&#x02013;<lpage>87</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.virol.2010.12.007">10.1016/j.virol.2010.12.007</ext-link>
<?supplied-pmid 21251689?><pub-id pub-id-type="pmid">21251689</pub-id></mixed-citation></ref><ref id="pone.0208936.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Groner</surname><given-names>AC</given-names></name>, <name><surname>Meylan</surname><given-names>S</given-names></name>, <name><surname>Ciuffi</surname><given-names>A</given-names></name>, <name><surname>Zangger</surname><given-names>N</given-names></name>, <name><surname>Ambrosini</surname><given-names>G</given-names></name>, <name><surname>Denervaud</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>KRAB-zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading</article-title>. <source>PLoS Genet</source>. <year>2010</year>; <volume>6</volume>:<fpage>e1000869</fpage>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pgen.1000869">10.1371/journal.pgen.1000869</ext-link>
<?supplied-pmid 20221260?><pub-id pub-id-type="pmid">20221260</pub-id></mixed-citation></ref><ref id="pone.0208936.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Matsui</surname><given-names>T</given-names></name>, <name><surname>Leung</surname><given-names>D</given-names></name>, <name><surname>Miyashita</surname><given-names>H</given-names></name>, <name><surname>Maksakova</surname><given-names>IA</given-names></name>, <name><surname>Miyachi</surname><given-names>H</given-names></name>, <name><surname>Kimura</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Proviral silencing in embryonic stem cells requires the histone ethyltransferase ESET</article-title>. <source>Nature</source>. <year>2010</year>; <volume>464</volume>:<fpage>927</fpage>&#x02013;<lpage>31</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature08858">10.1038/nature08858</ext-link>
<?supplied-pmid 20164836?><pub-id pub-id-type="pmid">20164836</pub-id></mixed-citation></ref><ref id="pone.0208936.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Quenneville</surname><given-names>S</given-names></name>, <name><surname>Verde</surname><given-names>G</given-names></name>, <name><surname>Corsinotti</surname><given-names>A</given-names></name>, <name><surname>Kapopoulou</surname><given-names>A</given-names></name>, <name><surname>Jakobsson</surname><given-names>J</given-names></name>, <name><surname>Offner</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>In embryonic stem cells, ZFP57/KAP1 recognize a methylated hexanucleotide to affect chromatin and DNA methylation of imprinting control regions</article-title>. <source>Mol Cell</source>. <year>2011</year>; <volume>44</volume>(<issue>3</issue>):<fpage>361</fpage>&#x02013;<lpage>72</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2011.08.032">10.1016/j.molcel.2011.08.032</ext-link>
<?supplied-pmid 22055183?><pub-id pub-id-type="pmid">22055183</pub-id></mixed-citation></ref><ref id="pone.0208936.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Bunch</surname><given-names>H</given-names></name>, <name><surname>Calderwood</surname><given-names>SK</given-names></name>. <article-title>TRIM28 as a novel transcriptional elongation factor</article-title>. <source>BMC Mol Biol</source>. <year>2015</year>; <volume>16</volume>:<fpage>14</fpage>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12867-015-0040-x">10.1186/s12867-015-0040-x</ext-link>
<?supplied-pmid 26293668?><pub-id pub-id-type="pmid">26293668</pub-id></mixed-citation></ref><ref id="pone.0208936.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>McNamara</surname><given-names>RP</given-names></name>, <name><surname>Reeder</surname><given-names>JE</given-names></name>, <name><surname>McMillan</surname><given-names>EA</given-names></name>, <name><surname>Bacon</surname><given-names>CW</given-names></name>, <name><surname>McCann</surname><given-names>JL</given-names></name>, <name><surname>D&#x02019;Orso</surname><given-names>I</given-names></name>. <article-title>KAP1 Recruitment of the 7SK snRNP Complex to Promoters Enables Transcription Elongation by RNA Polymerase II</article-title>. <source>Mol Cell</source>. <year>2016</year>; <volume>61</volume>(<issue>1</issue>):<fpage>39</fpage>&#x02013;<lpage>53</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2015.11.004">10.1016/j.molcel.2015.11.004</ext-link>
<?supplied-pmid 26725010?><pub-id pub-id-type="pmid">26725010</pub-id></mixed-citation></ref><ref id="pone.0208936.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Pavlaki</surname><given-names>I</given-names></name>, <name><surname>Alammari</surname><given-names>F</given-names></name>, <name><surname>Sun</surname><given-names>B</given-names></name>, <name><surname>Clark</surname><given-names>N</given-names></name>, <name><surname>Sirey</surname><given-names>T</given-names></name>, <name><surname>Lee</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>The long non-coding RNA Paupar promotes KAP1-dependent chromatin changes and regulates olfactory bulb neurogenesis</article-title>. <source>EMBO J</source>. <year>2018</year>; <volume>37</volume>(<issue>10</issue>): <fpage>e98219</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.15252/embj.201798219">10.15252/embj.201798219</ext-link></comment>
<?supplied-pmid 29661885?><pub-id pub-id-type="pmid">29661885</pub-id></mixed-citation></ref><ref id="pone.0208936.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>JS</given-names></name>, <name><surname>Valerius</surname><given-names>MT</given-names></name>, <name><surname>McMahon</surname><given-names>AP</given-names></name>. <article-title>Wnt/&#x003b2;-catenin signaling regulates nephron induction during mouse kidney development</article-title>. <source>Development</source>. <year>2007</year>; <volume>134</volume>:<fpage>2533</fpage>&#x02013;<lpage>39</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/dev.006155">10.1242/dev.006155</ext-link>
<?supplied-pmid 17537789?><pub-id pub-id-type="pmid">17537789</pub-id></mixed-citation></ref><ref id="pone.0208936.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Iglesias</surname><given-names>DM</given-names></name>, <name><surname>Hueber</surname><given-names>PA</given-names></name>, <name><surname>Chu</surname><given-names>L</given-names></name>, <name><surname>Campbell</surname><given-names>R</given-names></name>, <name><surname>Patenaude</surname><given-names>AM</given-names></name>, <name><surname>Dziarmaga</surname><given-names>AJ</given-names></name>, <etal>et al</etal>
<article-title>Canonical WNT signaling during kidney development</article-title>. <source>Am J Physiol Renal Physiol</source>. <year>2007</year>; <volume>293</volume>:<fpage>F494</fpage>&#x02013;<lpage>500</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajprenal.00416.2006">10.1152/ajprenal.00416.2006</ext-link>
<?supplied-pmid 17494089?><pub-id pub-id-type="pmid">17494089</pub-id></mixed-citation></ref><ref id="pone.0208936.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Schmidt-Ott</surname><given-names>KM</given-names></name>, <name><surname>Masckauchan</surname><given-names>TN</given-names></name>, <name><surname>Chen</surname><given-names>X</given-names></name>, <name><surname>Hirsh</surname><given-names>BJ</given-names></name>, <name><surname>Sarkar</surname><given-names>A</given-names></name>, <name><surname>Yang</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>&#x003b2;-Catenin/TCF/Lef controls a differentiation-associated transcriptional program in renal epithelial progenitors</article-title>. <source>Development</source>. <year>2007</year>; <volume>134</volume>:<fpage>3177</fpage>&#x02013;<lpage>90</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/dev.006544">10.1242/dev.006544</ext-link>
<?supplied-pmid 17693601?><pub-id pub-id-type="pmid">17693601</pub-id></mixed-citation></ref><ref id="pone.0208936.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Dihazi</surname><given-names>GH</given-names></name>, <name><surname>Jahn</surname><given-names>O</given-names></name>, <name><surname>Tampe</surname><given-names>B</given-names></name>, <name><surname>Zeisberg</surname><given-names>M</given-names></name>, <name><surname>M&#x000fc;ller</surname><given-names>C</given-names></name>, <name><surname>M&#x000fc;ller</surname><given-names>GA</given-names></name>, <etal>et al</etal>
<article-title>Proteomic analysis of embryonic kidney development: Heterochromatin proteins as epigenetic regulators of nephrogenesis</article-title>. <source>Sci Rep</source>. <year>2015</year>; <volume>5</volume>:<fpage>13951</fpage>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/srep13951">10.1038/srep13951</ext-link>
<?supplied-pmid 26359909?><pub-id pub-id-type="pmid">26359909</pub-id></mixed-citation></ref><ref id="pone.0208936.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>WJ</given-names></name>, <name><surname>Wittner</surname><given-names>BS</given-names></name>, <name><surname>Amzallag</surname><given-names>A</given-names></name>, <name><surname>Brannigan</surname><given-names>BW</given-names></name>, <name><surname>Ting</surname><given-names>DT</given-names></name>, <name><surname>Ramaswamy</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>The WTX Tumor Suppressor Interacts with the Transcriptional Corepressor TRIM28</article-title>. <source>J Biol Chem</source>. <year>2015</year>; <volume>90</volume>(<issue>23</issue>):<fpage>14381</fpage>&#x02013;<lpage>90</lpage>.</mixed-citation></ref><ref id="pone.0208936.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Rivera</surname><given-names>MN</given-names></name>, <name><surname>Kim</surname><given-names>WJ</given-names></name>, <name><surname>Wells</surname><given-names>J</given-names></name>, <name><surname>Driscoll</surname><given-names>DR</given-names></name>, <name><surname>Brannigan</surname><given-names>BW</given-names></name>, <name><surname>Han</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>An X chromosome gene, WTX, is commonly inactivated in Wilms tumor</article-title>. <source>Science</source>. <year>2007</year>; <volume>315</volume>(<issue>5812</issue>):<fpage>642</fpage>&#x02013;<lpage>5</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1137509">10.1126/science.1137509</ext-link>
<?supplied-pmid 17204608?><pub-id pub-id-type="pmid">17204608</pub-id></mixed-citation></ref><ref id="pone.0208936.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Rivera</surname><given-names>MN1</given-names></name>, <name><surname>Kim</surname><given-names>WJ</given-names></name>, <name><surname>Wells</surname><given-names>J</given-names></name>, <name><surname>Stone</surname><given-names>A</given-names></name>, <name><surname>Burger</surname><given-names>A</given-names></name>, <name><surname>Coffman</surname><given-names>EJ</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Haber</surname><given-names>DA</given-names></name>. <article-title>The tumor suppressor WTX shuttles to the nucleus and modulates WT1 activity</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2009</year>; <volume>106</volume>(<issue>20</issue>):<fpage>8338</fpage>&#x02013;<lpage>43</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0811349106">10.1073/pnas.0811349106</ext-link>
<?supplied-pmid 19416806?><pub-id pub-id-type="pmid">19416806</pub-id></mixed-citation></ref><ref id="pone.0208936.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Schmidt-Ott</surname><given-names>KM</given-names></name>, <name><surname>Barasch</surname><given-names>J</given-names></name>. <article-title>WNT/beta-catenin signaling in nephron progenitors and their epithelial progeny</article-title>. <source>Kidney Int</source>
<year>2008</year>; <volume>74</volume>(<issue>8</issue>):<fpage>10004</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="pone.0208936.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>L</given-names></name>, <name><surname>Chen</surname><given-names>DT</given-names></name>, <name><surname>Kurtyka</surname><given-names>C</given-names></name>, <name><surname>Rawal</surname><given-names>B</given-names></name>, <name><surname>Fulp</surname><given-names>WJ</given-names></name>, <name><surname>Haura</surname><given-names>EB</given-names></name>, <name><surname>Cress</surname><given-names>WD</given-names></name>. <article-title>Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions</article-title>. <source>J Biol Chem</source>. <year>2012</year>; <volume>287</volume>:<fpage>40106</fpage>&#x02013;<lpage>18</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M112.380865">10.1074/jbc.M112.380865</ext-link>
<?supplied-pmid 23060449?><pub-id pub-id-type="pmid">23060449</pub-id></mixed-citation></ref><ref id="pone.0208936.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>CC</given-names></name>, <name><surname>Gadd</surname><given-names>S</given-names></name>, <name><surname>Breslow</surname><given-names>N</given-names></name>, <name><surname>Cutcliffe</surname><given-names>C</given-names></name>, <name><surname>Sredni</surname><given-names>ST</given-names></name>, <name><surname>Helenowski</surname><given-names>IB</given-names></name>, <etal>et al</etal>
<article-title>Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children&#x02019;s Oncology Group</article-title>. <source>Clin Cancer Res</source>. <year>2009</year>; <volume>15</volume>(<issue>5</issue>):<fpage>1770</fpage>&#x02013;<lpage>8</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1078-0432.CCR-08-1030">10.1158/1078-0432.CCR-08-1030</ext-link>
<?supplied-pmid 19208794?><pub-id pub-id-type="pmid">19208794</pub-id></mixed-citation></ref><ref id="pone.0208936.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Robinson</surname><given-names>JT</given-names></name>, <name><surname>Thorvaldsd&#x000f3;ttir</surname><given-names>H</given-names></name>, <name><surname>Winckler</surname><given-names>W</given-names></name>, <name><surname>Guttman</surname><given-names>M</given-names></name>, <name><surname>Lander</surname><given-names>ES</given-names></name>, <name><surname>Getz</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Integrative genomics viewer</article-title>. <source>Nat Biotechnol</source>. <year>2011</year>; <volume>29</volume>(<issue>1</issue>):<fpage>24</fpage>&#x02013;<lpage>6</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nbt.1754">10.1038/nbt.1754</ext-link>
<?supplied-pmid 21221095?><pub-id pub-id-type="pmid">21221095</pub-id></mixed-citation></ref><ref id="pone.0208936.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Thorvaldsd&#x000f3;ttir</surname><given-names>H</given-names></name>, <name><surname>Robinson</surname><given-names>JT</given-names></name>, <name><surname>Mesirov</surname><given-names>JP</given-names></name>. <article-title>Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration</article-title>. <source>Brief Bioinform</source>. <year>2013</year>; <volume>14</volume>(<issue>2</issue>):<fpage>178</fpage>&#x02013;<lpage>92</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bib/bbs017">10.1093/bib/bbs017</ext-link>
<?supplied-pmid 22517427?><pub-id pub-id-type="pmid">22517427</pub-id></mixed-citation></ref><ref id="pone.0208936.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Afgan</surname><given-names>E</given-names></name>, <name><surname>Baker</surname><given-names>D</given-names></name>, <name><surname>van den Beek</surname><given-names>M</given-names></name>, <name><surname>Blankenberg</surname><given-names>D</given-names></name>, <name><surname>Bouvier</surname><given-names>D</given-names></name>, <name><surname>&#x0010c;ech</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update</article-title>. <source>Nucleic Acids Res</source>. <year>2016</year>; <volume>44</volume>(<issue>W1</issue>): <fpage>W3</fpage>&#x02013;<lpage>W10</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkw343">10.1093/nar/gkw343</ext-link>
<?supplied-pmid 27137889?><pub-id pub-id-type="pmid">27137889</pub-id></mixed-citation></ref><ref id="pone.0208936.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>K</given-names></name>, <name><surname>Li</surname><given-names>M</given-names></name>, <name><surname>Hakonarson</surname><given-names>H</given-names></name>. <article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title>. <source>Nucleic Acids Res</source>. <year>2010</year>; <volume>38</volume>(<issue>16</issue>):<fpage>e164</fpage>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkq603">10.1093/nar/gkq603</ext-link>
<?supplied-pmid 20601685?><pub-id pub-id-type="pmid">20601685</pub-id></mixed-citation></ref><ref id="pone.0208936.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Ramos</surname><given-names>AH</given-names></name>, <name><surname>Lichtenstein</surname><given-names>L</given-names></name>, <name><surname>Gupta</surname><given-names>M</given-names></name>, <name><surname>Lawrence</surname><given-names>MS</given-names></name>, <name><surname>Pugh</surname><given-names>TJ</given-names></name>, <name><surname>Saksena</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Oncotator: Cancer variant annotation tool</article-title>. <source>Hum Mutat</source>. <year>2015</year>; <volume>36</volume>(<issue>4</issue>):<fpage>E2423</fpage>&#x02013;<lpage>9</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/humu.22771">10.1002/humu.22771</ext-link>
<?supplied-pmid 25703262?><pub-id pub-id-type="pmid">25703262</pub-id></mixed-citation></ref><ref id="pone.0208936.ref065"><label>65</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>D</given-names></name>, <name><surname>Langmead</surname><given-names>B</given-names></name>, <name><surname>Salzberg</surname><given-names>SL</given-names></name>. <article-title>HISAT: a fast spliced aligner with low memory requirements</article-title>. <source>Nat Methods</source>. <year>2015</year>; <volume>12</volume>(<issue>4</issue>):<fpage>357</fpage>&#x02013;<lpage>60</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nmeth.3317">10.1038/nmeth.3317</ext-link>
<?supplied-pmid 25751142?><pub-id pub-id-type="pmid">25751142</pub-id></mixed-citation></ref><ref id="pone.0208936.ref066"><label>66</label><mixed-citation publication-type="journal"><name><surname>Anders</surname><given-names>S</given-names></name>, <name><surname>Pyl</surname><given-names>PT</given-names></name>, <name><surname>Huber</surname><given-names>W</given-names></name>. <article-title>HTSeq&#x02014;a Python framework to work with high-throughput sequencing data</article-title>. <source>Bioinformatics</source>. <year>2015</year>; <volume>31</volume>(<issue>2</issue>):<fpage>166</fpage>&#x02013;<lpage>9</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btu638">10.1093/bioinformatics/btu638</ext-link>
<?supplied-pmid 25260700?><pub-id pub-id-type="pmid">25260700</pub-id></mixed-citation></ref><ref id="pone.0208936.ref067"><label>67</label><mixed-citation publication-type="journal"><name><surname>Subramanian</surname><given-names>A</given-names></name>, <name><surname>Tamayo</surname><given-names>P</given-names></name>, <name><surname>Mootha</surname><given-names>VK</given-names></name>, <name><surname>Mukherjee</surname><given-names>S</given-names></name>, <name><surname>Ebert</surname><given-names>BL</given-names></name>, <name><surname>Gillette</surname><given-names>MA</given-names></name>, <etal>et al</etal>
<article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2005</year>; <volume>102</volume>(<issue>43</issue>):<fpage>15545</fpage>&#x02013;<lpage>50</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0506580102">10.1073/pnas.0506580102</ext-link>
<?supplied-pmid 16199517?><pub-id pub-id-type="pmid">16199517</pub-id></mixed-citation></ref></ref-list></back></article>